EBTNA Representative in Australia

Adam Mechler

Dr Mechler has received his PhD at the University of Szeged, Hungary,in 2001, in physics/materials science. His work involved high resolution atomic force microscopy (AFM) and Raman spectroscopy characterization of laser irradiated carbon surfaces. He spent three years with postdoctoral work at the University of California, Santa Barbara, where he was involved in several diverse projects including nano-viscosimetry, conductive polymers and transmembrane ionchannel activity. In 2004 he moved to Australia; after a five year fellowship at Monash University in 2009 he became faculty member at La Trobe University. Dr Mechler's primary research interest is the formation of complex nanostructures via intermolecular interactions, with three main focus areas: phospholipid membranes, membrane disrupting antimicrobial peptides, and peptide-based supramolecular frameworks.

EBTNA Representative in Austria

Martin Koller

After completing his doctoral thesis under supervision of Prof. Gerhart Braunegg, one of the most eminent pioneers in polyhydroxyalkanoate (PHA) research, Martin Koller was awarded his PhD degree in 2005 from Graz University of Technology, Austria, for his work on PHA production from dairy surplus streams; these activities were part of research in the EU-FP5 granted project WHEYPOL (“Dairy industry waste as source for sustainable polymeric material production”). Afterwards, he became a highly experienced senior researcher in the field of bio-mediated PHA production, encompassing design and development of continuous and discontinuous fermentation processes, and novel downstream processing techniques for sustainable biopolymer recovery from microbial biomass.

His focus of research is enhanced cost-efficiency of PHA production from surplus materials using both eubacteria and halophile archaea as whole cell biocatalysts. He holds numerous research articles in high ranked scientific journals, authored several chapters in biotechnological scientific books, gave a broad number of invited and plenary lectures at international conferences, and is active member of the Editorial Boards of distinguished scientific journals. From 2010 to 2012, he acted as coordinator of the EU-FP7 granted project ANIMPOL (“Biotechnological conversion of carbon containing wastes for eco-efficient production of high added value products”) which investigated the value-added conversion of waste streams from the animal processing industry towards structurally diversified PHA biopolyesters and their marketable follow up products. In addition to biopolymer exploration, he was also active in microalgal research and has long-year experience in biotechnological production of marketable compounds like bioethanol, polysaccharides, lactic acid or polyunsaturated fatty acids from renewable resources by various microorganisms such as yeasts, chlorophyta, bacteria, archaea, fungi or lactobacilli.

EBTNA Representative in Azerbaijan

Ilham Shahmuradov

He was born January 1, 1958. He is Head of Bioinformatics Laboratory,  Institute of Botany, Azerbaijan National Academy of Sciences and Professor in the Department of Medical Biology and Genetics, Azerbaijan Medical University. Scientific fields of interest are: structure and evolution of eukaryotic genomes; organization and expression of genes in eukaryotic genomes; organelle-to-nucleus gene transfer in plants; development of bioinformatics tools and databases.

He has published 60 papers. In collaboration with scientists from USA, UK, Russia and Pakistan, he developed a set of bioinformatics tools, including computer programs for identification of RNA polymerase II promoters and poly(A) sites. He is Secretary General of Azerbaijan Society of Biochemists and Molecular Biologists.

EBTNA Representative in Belgium

Vincenzo Costigliola

Vincenzo Costigliola graduated in Medicine from the University of Naples in 1972 and with distinction, in Anaesthesiology and Intensive Care from the University of Pisa in 1978. Completed studies in Rheumatology, Dermatology, Proctology, Oncology, Surgery, Drugs Abuse, Emergency Treatment, Disaster Action, Hospital Organization, Medical Teaching Methodology and Computer and Audio-Visual Training for the Medical Profession. Professional experience ranges from senior military positions as Chief of Medical Services in the Italian Navy, responsibility of the outpatients clinic of the Shape Hospital in Belgium and since 1972 family practice in Italy and Belgium. Medical advisor: OTAN; W.E.U. Bruxelles.

Member of the International Adisory Board at King Abdulaziz University J Djeddah Saudi Arabia President of EPMA (European Predictive, Preventive, Personalized Medicine http://www.epmanet.eu/ President of E.M.A. (European Medical Association ) http://www.emanet.org/ President of E.D.A. (European Depression Association) http://www.eddas.org/ President of I.R.M.A. ( International Rescue Medicine Association ) http://www.irmanet.eu/

EBTNA Representative in Bosnia and Herzegovina

Lejla Pojskic

Lejla Pojskic works in the field of Human molecular genetics at the Institute of Genetic Engineering and Biotechnology, University of Sarajevo, Bosnia and Herzegovina. Her research interests are into the molecular genetic basis of complex traits and novel genetic markers. Since 2005, she leads a research and diagnostics Lab for Human Genetics. Since 2013, she holds associate professorship at University of Sarajevo in the subject of Biotechnology and Genetics. As part of job description, provides support in genetic testing and advising to patients, families, and individuals at risk of genetic-related disorders. She is an active member of of Genetics Society in Bosnia and Herzegovina, Societty of Biochemists and Molecular Biologists in Bosnia and Herzegovina and European Society of Human Genetics.

EBTNA Representative in Canada

Satya Prakash

Dr. Satya Prakash is a Full Professor of Biomedical Engineering, Artificial Cells and Organs, Physiology, Experimental Medicine and Surgery in the Faculty of Medicine, at McGill University, Montreal, Quebec, Canada. Dr. Prakash research interest includes microbiome, probiotics, biomedicine, cancer microencapsulation, targeted delivery of therapeutic molecules and other biomedical applications. Specifically, his team is developing biotherapeutics for use in cancer, coronary heart, liver, gastrointestinal and other diseases and develop novel wound healing device and next generation of cardiac stents.

Dr. Prakash is leading author of more than 300 research papers and several book chapters, research and other scholarly articles. His publication list includes 70 approved/pending patents and 3 edited books.

Dr. Prakash is the winner of more than 30 international awards including “Medial for Outstanding Contribution to the Advancement of Science”, Overseas Scholar, Fraser, Monat and McPherson Award, Canadian Institute of Health Research Investigator Award, FRSQ Chercheure-Boursière and other awards. Dr. Prakash is listed in editorial boards of several distinguished journals. He holds MSc, M. Tech (BHU, India) and a Ph.D. from McGill University, Montreal, Quebec, Canada. Dr. Prakash is co-founder of MangoGen Pharma, Micropharma, and Proviva Pharma and currently serves as President, Director and various other positions.

EBTNA Representative in Chile

Dr. Francisco Fuentes is Assistant Professor of Agronomy and Forestry, Engineering and Medicine Faculties at Pontifical Catholic University of Chile. Dr. Fuentes has a B.S. in Agronomy (Crop Science) from University of Concepcion (Chile) and a Ph.D. in Agroforestry and Veterinary Sciences (Molecular Genetics) from University of Chile. He was a postdoctoral research fellow at Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey (USA). His research is primarily focused on development a quinoa breeding program under the extreme conditions of the Atacama Desert as well as in Mediterranean areas of central-southern Chile. The main objective of this breeding program is to develop improved lines of quinoa with high grain yield and nutritional content through selection and evaluation of native germplasm using conventional tools and DNA markers. He is an International Quinoa Expert for the Administration of Foreign Expert of Jilin Province (China) and a quinoa consultant for Food and Agriculture Organization of the United Nations in Chile. Dr. Fuentes has published several papers on quinoa studies and dietary phytochemicals associated with Nrf2–ARE pathway activation. He is also an Editorial Board member for scientific journals and Editor-in-Chief of Journal of Agronomy.

EBTNA Representative in Croatia

Anita Slavica

Anita Slavica was born in 1970 in Šibenik, Croatia. After degrees in Biotechnology (BSc and MSc) at Faculty of Food Technology and Biotechnology, University of Zagreb, she took PhD in Technical Chemistry at Graz University of Technology, Austria. She habilitated in 2006 in Physiology of Industrial Microorganisms at Department of Biochemical Engineering, the Faculty of Food Technology and Biotechnology, University of Zagreb. Since 2011 she is working as Associate Professor in Laboratory of Biochemical Engineering, Industrial Microbiology, Malting and Brewing Technology at the Department. She is lecturer at „Bioprocess Engineering“ and „Molecular Biotechnology“ MSc degree studies programme and „Biotechnology and Bioprocess Engineering“ PhD programme, researcher in several national/international research projects, supervisor of undergraduate and graduate students, and member of international conferences organizing and scientific comities. Scientific fields of her interest are: mass spectrometry; development and application of analytical methods related to monitoring of sustainable bioprocesses for production of biochemicals; protein expression, purification and characterization; enzyme kinetics; biochemical engineering and industrial microbiology; TT and IPR.

EBTNA Board in Croatia

Anita Slavica (Coordinator)
Bozidar Santek
Srdjan Novak
Predrag Horvat
Mirela Ivancic Santek
Jagoda Suskovic
Ivan Kresimir Svetec
Visnja Gaurina Srcek
Jadranka Frece
Antonio Starcevic

EBTNA Members in Croatia

Vesna Zechner-Krpan
Suncica Beluhan
Tonci Rezic
Vlatka Petravic Tominac
Blazenka Kos
Jasna Beganovic
Visnja Bacun-Druzina
Ksenija Durgo
Ivana Radojcic Redovnikovic
Ksenija Markov
Dušica Vujaklija
Damir Stanzer
Jasna Mrvcic
Vinko Krstanovic
Natalija Velic
Kresimir Gjuracic

EBTNA Represantative in Ecuador

Andrés Izquierdo Romero

Andrés Ricardo Izquierdo Romero was born in 1983, in Quito (Ecuador), Biotechnology professional qualified by studies in engineering and environmental sciences. Years of teaching and academic research experience. Specialties: Environmental monitoring, analysis and remediation, ecotoxicology, molecular biology techniques and soil microbiology.

Experience:

2014-to date: Associate Professor of Microbiology II and Environmental Impact Assessment, Department of Life Sciences and Agriculture, Universidad de las Fuerzas Armadas – ESPE, Sangolqui, Ecuador

2015-2016: Professor of Management of Hazardous Waste, Master of Environmental Management Systems,   Universidad de las Fuerzas Armadas – ESPE,  Graduate Management Unit, Ecuador.                                                                                                               

2014: Professor of Environmental Management at the School of Military Sciences, Third Military Year, Universidad de las Fuerzas Armadas – ESPE, Escuela Superior Militar Eloy Alfaro, Ecuador.

2014: Professor of  Environmental Biotechnology, Biorremediation, Biosegurity in Faculty of Engineering and Agricultural Sciences (FICA),  Universidad de las Américas UDLA, Ecuador                     

2012-2013: Ph.D Student Visitor, Université Blaise Pascal, Laboratoire Microorganismes: Génome et Environnement , Clermont-Ferrand, France                                         

2008: Professor of Molecular Biology, Escuela Politécnica del Ejercito, Sangolqui, Ecuador.

Awards:

Scholarship Award recipient. Army Polytechnic School. 2002 - 2006

Secretariat of Science and Technology Fellowship recipient. 2009-2013

Research Interests:

• Molecular biology techniques and soil microbiology
• Isolation and identification of extremophiles
• Bioremediation of hydrocarbons and toxic heavy metals
• Ecotoxicology
• Nanotechnology

Member in the Editorial Board of the Integrative Omics and Molecular Biology.

Member in the Editorial Board of the Journal of Toxicology and Environmental Health Sciences, ISSN:2006-9820,  

Editor-in-Chief of the World Research Journal of Agronomy.

Member in the Scientific Board of the International Institute of Chemical, Biological & Environmental Engineering .

Member in the Editorial Board of the International Journal of Biological Sciences and Applications (ISSN: 2375-3811).

Member in the Editorial Board of the American Journal of Science and Technology (ISSN: 2375-3846).

Member in the Editorial Board of the Revista Científica UDO Agrícola. ISSN: 1317-9152.

Member in the Editorial Board of the Jornal of BiotechnologyResearchCenter, ISSN: 1815-1140.

Member in the Editorial Board of the European Journal of Academic Essays. ISSN 2183-1904 (online). ISSN   2183-3818 (print).

Member in the Editorial Board of the International Journal of Applied and Pure Science and Agriculture (IJAPSA), SSN (Online): 2394-5532, ISSN (Print): 2394-823X.

Member in the Editorial Board of International Journal of Innovations in Biological and Chemical Sciences (IJIBCS), ISSN 2047 9093

Member in the Editorial Board of the International Journal of Vegetable Science, ISSN 1931-5260 (Print), 1931-5279 (Online), 

REVIEWER FOR INTERNATIONAL JOURNALS

International Reviewer of Australian Journal of Crop Science (Australia).

International Reviewer of Journal of Herbs, Spices & Medicinal Plants, America.

International Reviewer for Journal of Agricultural, Food and Environmental Sciences. America.

International Reviewer for Journal of Plant Studies, Canada.

EBTNA Representative in Estonia

Lembit Nei

Professor of Environmental Chemistry

Education

1993–1994 Oxford University - the Royal Society postdoctoral fellowship; 1989–1991 Moscow State University, PhD (chemistry); 1975–1980 Tartu State University, chemistry diploma (MSc), thesis recognized with an award of excellence; 1964–1975 Tallinn Secondary School No 7 (English College)

Career

2005–… Tallinn University of Technology, Tartu College, Professor; 2005–… Tallinn University of Technology, Tartu College, Director; 2000–2003 Estonian Agricultural University, Vice-rector; 1997–2005 Estonian Agricultural University, Professor of Environmental Chemistry; 1994–2005 Estonian Agricultural University, Environmental Protection Institute, Director; 1993–1994 University of Oxford, Physical Chemistry Laboratory, Professor Compton Research Group, The Royal Society postdoctoral fellow; 1989–1993 Environmental company "ELVI-Aqua", Chief Chemist; 1980–1989 Tartu State University, research associate

Experience

2018−... Oxford University, Physical & Theoretical Chemistry Laboratory, Visiting Professor (1 month); 2018−... Michigan State University, Academic Visitor (2 months); 2013−... University of South Florida St Petersburg - Visiting Professor - 6 months; 2005−… Tacoma Community College - Visiting Professor (2 months); 1997−1998 The Association of Estonian Scientists, Chairman (one-year elected position)

Research

Pharmaceuticals in the environment, their migration and degradation. Electroanalysis for environmental monitoring. Novel methodologies for environmental monitoring.

EBTNA Representative in France

Michel Salzet

Since 1998, Professor Michel Salzet is the director of the CNRS then INSERM Laboratory at the University of Lille 1. PRISM is now an European Associated Laboratory with department of Cancer and surgery of Imperial College of London and name, Lancet. Pr. Salzet received his PhD in Biochemistry at the University of Lille 1 in 1993, where he has served as Chair of Immunology since 1997. After his PhD, Pr. Salzet worked as Associate Researcher for one year at the Institute of Neurosciences at Stony Brook University (USA), and was subsequently nominated as Senior Research Scientist at the Beth Israel, Mind Body Institute of Harvard Medical School. He became a member of the Institut Universitaire de France in 1998. Pr. M. Salzet was member from 2009 to 2012 of the core group and the standing committee of the LESC of European Science Foundation and member of management committee of the forward looks in Personalized Medicine for the European Citizen. From 2009 to 2012, he has been nominated at the CNRS as a scientific delegate at the international.  Pr. Salzet is an expert in the field of Neuroimmunology and Proteomic. Salzet has published 274 original articles and 20 book chapters, 4 vulgarization articles and 158 proceedings. He was invited in 84 international conferences and seminars. He is co-founder of IMABIOTECH SAS in 2009 and CLIC-IMAGING platform 2014. He supervised 28 PhD. Pr. Salzet currently has 16 patents. After being the co-director of the doctoral school in Biology and Heath of Lille from 1998 to 2003, he created in 2000, tthe Proteomics Master Degree Program of Lille, which is now recognized as an EU Master. He is presently distinguished Professor (PRECE2) with a chair in immunology since 1997. He received in 1993 the Wicart Hagelstein Medaillon and in 2003 the “Grand Prix des Sciences” by the Science Academy of the Sciences and Letters of Lille. He got the Altran (2014) and MATWIN (2015) innovation prices.

EBTNA Representative in Greece

Anargyros Moulas

Professor Anargyros Moulas is currently Dean of the School of Agriculture and Food Technology and Nutrition of the Technological Education Institute T.E.I. of Thessaly, Greece and head of the laboratory of chemistry and biochemistry. He has a degree in Chemistry (BSc, Aristotle University of Thessaloniki, Greece) and Ph.D. in Biochemistry from the University of Ioannina, Greece. After a post-doc in Biochemistry at the University of Ioannina, he was elected assistant professor at the Technological Education Institute T.E.I. of Larissa, Greece in 1998. In 2000 he was visiting scientist at the Medical College of Virginia, USA and between 2001 and 2002 researcher at the Human Nutrition Laboratory of the USDA, Beltsville MD, USA. In 2005 was elected professor and from 2009 to 2012 he was president of the Department of Nutrition of T.E.I. of Larissa. Between 2012 and 2014 he was visiting researcher at the University of Medicine and Dentistry of New Jersey (currently Rutgers Biomedical), Newark, USA. Has published several papers on fat soluble vitamins and oxidative stress and holds one international patent.

His research interests include health aspects and molecular mechanisms of action of vitamin D and other fat soluble vitamins, functional foods, antioxidants and oxidative stress, controlled release of drugs and chromatographic/spectroscopic methods.

EBTNA Representative in Hungary

Miklos Kellermayer

Miklós Kellermayer graduated in medicine (1988) and earned his PhD (1998) at the University of Pécs, Hungary. Having had international research experience in single-molecule biophysics (1989-1993 University of Washington, Seattle; 1995-1997 Washington State University, Pullman; 1998 University of Oregon, Eugene; 2001 University of California, Berkeley), he currently focuses on nanobiotechnology, biomolecular mechanics, cytoskeletal nanobiology, protein folding and misfolding, and the nanomechanics of lipid and viral systems. Since 2008 he is the chairman of the Department of Biophysics and Radiation Biology at Semmelweis University, Budapest, Hungary. He served as the university's Vice Rector for Science, Innovation and International Affairs (2009-2012) and the Vice Dean of the Medical School (2013-2015). He established and supervises the Georg von Békésy Biophysics Research Center that houses state-of-the-art instrumentation for the imaging and manipulation from single molecules to small-animal organisms. He is currently the president of the Biophysics Subgroup of the Hungarian Academy of Sciences and the Vice President of the Hungarian Biophysical Society. He was recently elected the Dean of the Medical Faculty at Semmelweis University for the period of 2019-2014. He has tutored 11 PhD graduates. He is a Howard Hughes Medical School International Alumnus and has authored more than one hundred original research papers.

EBTNA representative in Iran

Mohammad Amin Hejazi

Mohammad Amin Hejazi was born March 27, 1970. He received the B.Sc. and M.Sc. degrees from University of Tabriz and Tarbiat Modaress University, respectively. He made Ph.D on Food Biotechnology at Wageningen University, The Netherlands in 2003. After completing a Postdoctoral period at the same university, he came back to Iran an appointed as the head of Microbial Biotechnology and Biosafety Department at Agricultural Biotechnology Research Institute of Iran (ABRII).

He is Founder of Food Biotechnology Department and Head of Branch for Northwest and West region, ABRII since 2007. He is taking some other responsibilities to promote biotechnology sector at national and regional levels.

He coordinated and implemented several research projects, and published 64 research papers in peer reviewed journals, 7 patents, a book, and 127 conference proceedings and book chapters. He gives lectures at different universities for postgraduate students. He received several international and national awards for his outstanding achievements in the field of biotechnology.

EBTNA Represantative in Ireland

Gary Henehan

Background

Professor Henehan has experience of research and development in academia and in the food, pharmaceutical and biotechnology industries. He lectures in biochemical, toxicological and pharmacological aspects of Food Science and Environmental Health. His research includes collaborative work with the School of Biochemistry and Immunology at Trinity College Dublin and the School of Biotechnology, Dublin City University.

Research Interests

• Professor Henehan has been involved, along with Dr Bourke and Dr Dunne of the School in the development of novel antimicrobial agents from carbohydrate fatty acid conjugates. He is also involved, with Dr Frias of this School in the isolation of novel lipases for applications in organic synthesis.

Current Research Projects

• Isolation of Novel Lipase Enzymes for Applications in Biocatalysis.
• Role of the Kvβ2 subunit of the Shaker potassium channel. This subunit is involved in the modulation of channel activity in excitable cells.
• Pathogenesis of Helicobacter pylori-induced gastritis: This organism colonises the gastric mucosa and is thought to cause gastritis by production of toxic aldehydes from dietary precursors. The project is examining pathways of metabolism of toxic aldehydes in H pylori with a view to modelling the exposure of the gastric mucosa to such aldehydes. The project is funded by the Health Research Board.
• Synthesis of fatty acid sugar esters: The esterification of fatty acids to sugars has led to the production of useful food additives. In particular these compounds have been employed as emulsifiers. More recently it has been found that these compounds have useful antibacterial properties. Current work in this area in collaboration with Dr Seamas Cassidy is examining esterification of fatty acids to lactose. Chemical synthesis using organotin compounds and enzymatic synthesis using immobilised lipases is being investigated.

EBTNA Representative in Israel

Robert Marks

Prof. Robert S. Marks, (PhD, Weizmann Institute and postdoctorate University of Cambridge) has developed biosensors at the Ben Gurion University, Israel, in the last 15 years resulting in over 75 publications, 20 chapters, 4 granted patents, and founded 4 start-up companies. His work consists in the development of fiber-optic immunosensors (Ebola, Dengue, West Nile, Rift Valley fever viruses, and Hepatitis C, Brucella), and fiber-optic bioreporters biosensors for water monitoring (genotoxicity, cytotoxicity, heavy metals, endocrine disrupting compounds).

Other projects consist in nanotoxicity, development of a reverse genetics cell reporter assay to influenza, a bioreporter panel for the discovery of antibiotics from difficult to grow microorganisms, the discovery of quorum sensor inhibitors as well as epitopes from ebola sudan virus for diagnostics; nanobiotechnology, including nanolithography, nanometer scale structured surfaces for optical enhancement in fluorescence, Raman and infra-red, the creation of tailored nanomaterials including conductive or affinity hydrogels. He has chaired 13 conferences, has given 57 invited and 45 contributed lectures at conferences, 130 posters presentation with colleagues and students, and 130 academic lectures around the world.

He is an adjunct Professor at the University of Maryland and an invited Professor several Universities in, USA (1), Finland (1), France (3) and Italy (1).

EBTNA Representative in Italy

Fabrizio Bruschi

University of Pisa

Fabrizio Bruschi was born in Pisa in 1954. He graduated in 1979 in Medicine, University of Pisa, Pisa, Italy, score: 110/110 cum laude; Haematology Specialization, University of Pisa, Italy, score: 70/70 cum laude. He obtained the Certificat d'Etudes Superieures in Immunologie et Pathologie Parasitaires at the Université Pierre et Marie Curie, Paris, France. Researcher since 1984, confirmed since 1987, then Associate Professor in General Pathology, Medical Faculty, University of Perugia, Italy (1992-1997), then University of Pisa, Italy until 2002 when he has obtained the position of Professor of Parasitology in the Faculty of Medicine of the same University. Since then he is also in charge of the Parasitology Sector of University Microbiology Laboratory of the University Hospital in Pisa.

The interests of Prof. F. Bruschi are represented mainly by host-parasite relations in helminth infections such as trichinellosis of which different aspects, both experimental and clinical have been studied. Prof. Bruschi has been coordinator of different research projects both at local and at national (MURST and Ministry of Health) levels on trichinellosis. He was appointed as 1st Vice-President of the European Federation of Parasitologists since 2000 up to 2008 and in virtue of this position he has participated to the Scientific Consultation Group of ECDC in Stockholm.

He participated to the Committee of the International Commission on trichinellosis for the compilation of the guidelines for the diagnosis and treatment of human trichinellosis, as well as in that for the preparation of the guidelines for the animal and human serology. Recently, he was involved in the preparation of the W.H.O.-F.A.O.-O.I.E. guidelines for human trichinellosis. At present he is Vice-President of the Società Italiana di Parassitologia and member of the Executive Committee of the International Commission on trichinellosis. Since 2010 he is member of ESCMID and he participates to the study group of Clinical Parasitology.

He is author or co-author of over 130 publications among which chapters in books from international publishers and Editor of books or journal supplements. He is Associate/Receiving Editor for Medical Parasitology of the journal Parassitologia and he is in the editorial board of the new Journal of Infectious Diseases and Immunity and of the advisory board for Clinical Parasitology of the journal Turkiye Klinikleri Journal of Medical Sciences.

EBTNA Representative in Kazakhstan

Alma Kokhmetova

Present Position:
Head of Lab. Genetics & Breeding of the Institute of Plant Biology and Biotechnology of National Biotechnological Center Republic of Kazakhstan

Education:
Doctor of Biological Sciences (D.Sci.). 2005. Genetics. Al-Farabi Kazakh National University, Faculty of Biology, Almaty, Kazakhstan.
PhD. 1991. Plant Breeding, Kazakh Institute of Agriculture, Almalybak, Kazakhstan.
MSc, 1983. Agronomy Kazakh Agricultural Institute, Almaty, Kazakhstan.

Period of study abroad:
• 01.12.1995-31.01. 1996. Israel, study program “Biological and Physical aspects of Crop Production in arid zones”. Certificate of attendance.
• 08-22.02.1997. Iowa State University and Kansas State University, USA, Cochran Fellowship Program “Seed&Seed Technology”. Certificate of attendance.
• 07. 07. 1997-26.07. 1997, Sharvas, Hungary, Darvin Initiative training course in Plant conservation. Certificate of attendance.
• 02.11.1998-11.12.1998. 4th International Programme on Strategies for Sustainable Agriculture and Rural Development, National Institute of Rural Development, Hyderabad, India. Certificate of attendance.
• 14.03-25.06.1999. The Netherlands, Wageningen Agricultural University, International Course on Applied Plant Breeding. Fellowship program. Certificate  with credits.
• 10.05. – 21.05. 1999. The third Int. Course on Plant Variety Protection, Wageningen, The Netherlands. Certificate of attendance.
• 28.03.2006-30.05.2006. USA, Washington State University, Pullman, WA. Dept. of Plant Pathology. Training under ICAR project: «Marker Assisted Selection and Wheat Breeding».
• 10.12.2009-24.12.2009. ICARDA, 2009 (Aleppo, Syria). Specialized Training Course on Seedling Assessment of Wheat Rusts held. Certificate of attendance.

EBTNA Representative in Kosovo

Bajram Berisha

Professor Bajram BERISHA, (born in Suharekë, Republic of Kosova) is an Albanian researcher and international university professor of Technical  University of Munich (Germany), University of Prishtina (Kosovo) and Agriculture University of Tirana (Albania). Prof. Dr. Dr. habil. Bajram Berisha, graduated from the University of Prishtina (UP), Kosovo (BSc., 1986), University of Ljubljana, Slovenia (MSc., 1992) and Technical University of Munich (TUM), Germany (PhD, 2001 and habilitation, 2007). He is a senior scientist with a long research experience in the area of animal physiology, genetics and biotechnology and author of numerous original research articles and other publications published in the best journal with high impact factor (his current h-index >30). Professor Bajram Berisha has a special interest in field of animal biotechnology. His research work is concentrated in the very important steps in the regulation of final follicle growth and especially of angiogenesis during follicle development, periovulation as well as corpus luteum formation and function. Currently he focuses on the action of locally produced angiogenic and lymphangiogenic factors in ovary during different physiological stages. From 1996-2008 he worked at the Technical University of Munich and since 2008 he is full Professor at the University of Prishtina in Kosovo in field of animal genetics and biotechnology. Currently Prof. Bajram Berisha is a Visiting Professor at the Technical University of Munich, (Chair of Animal Physiology and Immunology, Weihenstephan). For his contributions to the Technical University of Munich (TUM).

EBTNA Representative in Latvia

Anna Zajakina

1. NAME: Anna Zajakina MAILING ADDRESS: Cell Biology Department, Biomedical Research and Study Centre (BMC), Ratsupites Str., 1, Riga LV-1067, Latvia. PHONE: 371 29150597, FAX NUMBER: 371 67442407, E-mail: Anna@biomed.lu.lv

2. AGE. DATE AND PLACE OF BIRTH: 37 years; October 14, 1974. Riga.

3. EDUCATION: 2005: Research Doctoral degree/PhD in molecular biology, PhD thesis “Reconstruction of hepatitis B virus in vivo”, University of Latvia. Supervisors – Dr.Habil Biol. T. Kozlovska, Prof. Dr. P. Pumpens. Opponents - Prof. V. Baumanis (Latvia), Prof. W. H. Gerlich (Germany); Prof. K. Sasnauskas (Lithuania). 1998: Master Diploma - “Development of recombinant RNA packaging vectors on the basis of bacteriophage Qβ”, University of Latvia, major disciplines - molecular biology & biochemistry. Supervisor - Dr.habil.biol. T. Kozlovska.

International education: 2005, June: FEBS fellowship “Advanced light microscopy”, Semmering, Austria. 2004, March: EuroLabCourse fellowship „Vectorology in gene therapy”, Paris, France. 2002, October: EMBO practical course “Cell Biology of Virus Infection”, Heidelberg, Germany. 2001, September: FEBS fellowship „International Summer School on Protein Biology: From Synthesis to Function and Disease”, Spetses, Greece. 1997, March-May: Sweden and Latvian cooperation fellowship “Elective course in Pharmacology, with special reference to target proteins for drug development”, Uppsala, Sweden. 1997, June: FEBS fellowship “Basic and specialized techniques in cell biology”, Aarhus, Denmark. 1996, June: University of Rostock fellowship „International Hanseatic student days: Advanced methods in experimental medicine”, Rostock, Germany.
Additional education: 2010-present Economics and Management faculty, University of Latvia, major discipline – project management, accounting (third year student).

4. Employment history: 09/2008-present: senior researcher, group leader, BMC, Riga, Latvia; 10/2005-12/2008: lecturer, University of Latvia, Biology faculty; 12/2004-09/2008: researcher, BMC, Riga, Latvia; 05/2003-12/2004: career break, maternity leave; 09/1999-05/2003: scientific assistant, BMC, Riga, Latvia 05/1998-09/1999: career break, maternity leave; 07/1994-05/1998: assistant, undergraduate student, BMC, Riga, Latvia International experience: 2009, October-December: scientific work in Latvia/France cooperation project „OSMOZE” „Intracellular transport of Hepatitis B virus core antigen”, University of Bordo, France. 2008, November-December: scientific work in Latvia/France cooperation project „OSMOZE” „Analysing the intracytosolic transport of chimeric hepatitis B viruscapsids exposing domains of the HIV integrase”, University of Bordo, France. 1997, June-September: scientific work in project “Cytokine pathways in hematopoietic cells”, University of Rostock, Germany.

5. Latvian and international projects: „Elaboration of delivery system for DNA, RNA, protein, peptide, and smal molecule medical preparations”, State Research Programme (2010-2014) main participant, scientific...
“Novel model of HBV infection and a technology for antiviral agent evaluation”, 2011-2013 European Regional Development Fund (ERDF) 2010/0233/2DP/2.1.1.1.0/10/APIA /VIAA/075
„Modelling of HBV replication” (ERDF, 2006-2008). Main participant. Nr. VPD1/ERAF/CFLA/05/APK/2.5.1./000018/008; „Reconstruction of HBV particles in vivo”. The ESF and Ministry of Education and Science grant for young scientists (2005-2008). Head of the project. VPD1/ESF/PIAA/04/NP/3.2. 3.1/0002/0007; 3630 „Analysing the intracytosolic transport of chimeric heptitis B viruscapsids exposing domains of the HIV integrase „ (2007-2008) OSMOZE project. Participant. National coordinator. “Combined immune and gene therapy for chronic viral hepatitis”, EU project Contract No QLK2-Ct-2000-01476. „A therapeutic DNA vaccine against chronic hepatitis B virus infections delivered by in vivo electroporation”. The Swedish Institute Project (2004-2007). „Artificial chimeric proteins as diagnostic, vaccine, and gene therapy carriers”. (2004-2007) QoL Project, Marie Curie Training Site; „Construction of HBV/HCV replication models for the design and screening of putative antiviral drugs”. (2003-2005) Taiho Project: „Hepatitis B virus assembly, structure and entry into new host cells”. (1999-2001) KIRT programme.

6. MENTORING/TUTORING ACTIVITIES Doctoral thesis supervision (in progress): „Modelling of Hepatitis B virus (HBV) infection in differentiated stem cells”, Diana Legzdina PhD student, BMC; „HBV genome replication in vivo using alphaviral vectors”, Vladimirs Hutornojs PhD student, BMC; „Alphaviral vectors as gene delivery tools for cancer treatment”, Jelena Vasilevska PhD student, BMC;

7. AWARDS 08/2010: oral presentation prize, EMBO Advanced symposium, „Recombinant Semliki Forest Virus distribution in mice”, authors: A.Zajakina, J.Vasilevska, D.Skrastina, T.Kozlovska.  Kuopio, Finland. 05/2005: L’ORÉAL-UNESCO & Latvian Academy of Sciences award “For Women in Science”. 12/1998: : Annual prize of Latvian Academy of Science and joint-stock company "Grindeks” for young scientists, the best Msc. diploma thesis „ Development of recombinant RNA incapsidation system on the basis of bacteriophage Qβ”. Supervisor Dr. habi. biol.T. Kozlovska.

8. Profeccional activities: evaluation expert of FP7-PEOPLE-2012-IEF-IIF-IOF – LIFE panel proposals; national expert of Latvian Academy of Sciences;

Members
Karina Spunde

EBTNA Represantative in Lithuania

Daumantas Matulis

Daumantas Matulis

Head of Laboratory of Biothermodynamics and Drug Design

Institute of Biotechnology

Vilnius university

Graiciuno 8

LT-02241, Vilnius

Tel. +370-5-269-1884

matulis@ibt.lt

daumantas.matulis@bti.vu.lt

http://www.ibt.lt

Education

Professional experience

Teaching

1. “Molecular Biophysics” course for Bachelor students, Faculty of Natural Sciences, VilniusUniversity, 2011- present.
2. “Biophysical Chemistry of Proteins” course for the Master students, Faculty of Natural Sciences, VilniusUniversity, 2005- present.
3. “Structure, Folding and Dynamics of Proteins and Their Complexes”, FEBS course, Budapest, Hungary, 2009.
4. Life Sciences Summer Undergraduate Research Program, University of Minnesota, 1999 – 2000.
5. Biochemistry Laboratory course, University of Minnesota, 1997 – 1999.
6. “Biophysical Chemistry of Proteins”, textbook for the Master students, Vilnius University.

Awards, achievements

1. Lithuanian National Science award 2012. 
2. Life Science Baltics Startup Session, Lithuania, Vilnius. 2012 (second place).
3. The Best Poster award in the Conference “Biochemija ir biofizika Vilniaus universitete”, Lithuania, Vilnius. 2012 (third place).
4. The Best Poster award in the Conference „XVII International Society of Biological Calorimetry (ISBC) Conference“, Germany, Leipzig. 2012 (second place).
5. The Best Poster award in the Conference “ESBES+ISPPP+ISB“, Italy. 2010.
6. ScanBalt Bridge Baltic Sea Region Award, Sweden. 2009.
7. Public advisor to the President of Lithuania for the issues of emigration and repatriation, 2007-2009.
8. Selected as Lithuanian representative young scientist in the book “Portraits of Science. Scientists of Tomorrow” by European Federation of Pharmaceutical Industries and Associations, 2008.
9. Award “Direction-Home” given to Lithuanian scientist selected by an independent Swedish-Lithuanian scientific council, by “Telia Sonera” Inc., Sweden, 2007.
10. Robert Jenness Award by University of Minnesota Department of Biochemistry, Molecular Biology, and Biophysics for the best postdoctoral associate in 2000.
11. National high school Olympic competition in chemistry, third place, 1988.

Scientific Publications

1. Capkauskaite, E., Zubriene, A., Smirnov, A., Torresan, J., Kisonaite, M., Kazokaite, J., Gylyte, J., Michailoviene, V., Jogaite, V., Manakova, E., Grazulis, S., Tumkevicius, S., Matulis, D. 2013. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII. Biorg. Med. Chem. 21: 6937-6947.
2. Petrauskas, V., Gylyte, J., Toleikis, Z., Cimmperman, P., Matulis, D. 2013. Volume of Hsp90 ligand binding and the unfolding phase diagram as a function of pressure and temperature. Eur. Biophys. J. 42: 355-362.
3. Dudutiene, V. Zubriene, A., Smirnov, A., Gylyte, J., Timm, D., Manakova, E., Grazulis, S., Matulis, D. 2013. 4-Substituted-2,3,5,6-tetra?uorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. Bioorg. Med. Chem. 21: 2093-2106.
4. Jogaite, V., Zubriene, A., Michailoviene, V., Gylyte, J., Morkunaite, V., Matulis, D. 2013. Characterization of Human Carbonic Anhydrase XII Stability and Inhibitor Binding. Bioorg. Med. Chem. 21: 1431-1436.

1. Pirrie, L., McCarthy, A. R., Major, L., Morkunaite, V., Zubriene, A., Matulis, D., Lain, S., Lebl, T., Westwood, N. J. 2012. Discovery and Validation of SIRT2 Inhibitors Based on Tenovin-6: Use of a H-NMR Method to Assess Deacetylase Activity. Molecules. 17: 12206-12224.
2. Sharp, S. Y., Roe, S. M., Kazlauskas, E., Cikotiene, I., Workman, P., Matulis, D., Prodromou, C. 2012. Co-Crystalization and In Vitro Biological Characterization of 5-Aryl-4-(5-Substituted-2-4- Dihydroxyphenyl)-1,2,3- Thiadiazole Hsp90 Inhibitors. Plos One. 7(5): e44642.
3. Labanauskas, L., Dudutiene, V., Urbelis, G., Sarlauskas, J., Sudzius, J., Matulis, D., Striela, R., Zilinskas, A. 2012. Synthesis of substituted 2λ 4 δ 2-[1,2,3]thiadiazolo[3,4-c]benzimid-azoles and 2λ 4 δ 2-[1,2,3,5]thiatriazolo[3,4-c]benzimidazoles. Arkivoc. 8: 17-26.
4. Kazlauskas, E., Petrikaite, V., Michailoviene, V., Revuckiene, J., Matuliene, J., Grinius, L., Matulis, D. 2012. Thermodynamics of Aryl-dihydroxyphenyl-thiadiazole Binding to Human Hsp90. Plos One. 7(5): e36899.
5. Toleikis, Z., Cimmperman, P., Petrauskas, V., Matulis, D. 2012. Serum albumin ligand binding volumes using high pressure denaturation. Journal of Chemical Thermodynamics. 52: 24-29.
6. Toleikis, Z., Cimmperman, P., Petrauskas, V. and Matulis, D. 2011. Determination of the volume changes induced by ligand binding to heat shock protein 90 using high-pressure denaturation. Analytical Biochemistry. 413: 171-178.
7. Zubriene A., Kazlauskas E., Baranauskiene L., Petrauskas V., Matulis D. 2011. Isothermal Titration Calorimetry and Thermal Shift Assay in Drug Design. European Pharmaceutical Review. 16 (3): 56-59.
8. Cimmperman, P and Matulis, D. 2011. Protein Thermal Denaturation Measurements via a Fluorescent Dye. Invited review to the book: RSC Biomolecular Sciences No. 22. Biophysical Approaches Determining Ligand Binding to Biomolecular Targets: Detection, Measurement and Modelling. Edited by A. Podjarny, A. Dejaegere, and B. Kieffer. Royal Society of Chemistry. Chapter 8.
9. Petrikaite, V., Matulis, D. Thermodynamics of Natural and Synthetic Inhibitor Binding to Human Hsp90. In: "Application of Thermodynamics to Biological and Materials Science". Ed. Mizutani Tadashi, 2011, 77-92.
10. Petrikaite, V., Matulis, D. 2011. Natural and synthetic inhibitors binding to human Hsp90 and their clinical application. Medicina (Kaunas). 47 (8): 413:420.
11. Petrikaite, V. and Matulis, D. 2010. Thermodynamics of Natural and Synthetic Inhibitor Binding to Human Hsp90. Thermodynamics. 77- 92.
12. Capkauskaite, E., Baranauskiene, L., Golovenko, D., Manakova, L., Grazulis, S., Tumkevicius, S., and Matulis, D. 2010. Indapamide-like benzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, and XIII. Bioorg. Med. Chem. 18: 7357-64.
13. Sudzius, J., Baranauskiene, L., Golovenko, D., Matuliene, J., Michailoviene, V., Torresan, J., Jachno, J., Sukackaite, R., Manakova, L., Grazulis, S., Tumkevicius, S., and Matulis, D. 2010. 4-[N-(Substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII. Bioorg. Med. Chem. 18: 7413-21.
14. Baranauskiene, L., Hilvo, M., Matuliene, J., Golovenko, D., Manakova, E., Dudutiene, V.,  Michailoviene, V., Torresan, J., Jachno, J., Parkkila, S., Maresca, A., Supuran, C. T., Grazulis, S., and Matulis, D. 2010. Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides, J. Enz. Inhib. Med. Chem., 25(6): 863-70.
15. Zurawska, A., Urbanski, J., Matuliene, J., Baraniak, J., Klejman, M. P., Filipek, S., Matulis, D. and Bieganowski, P. 2010. Mutations that increase both Hsp90 ATPase activity in vitro and Hsp90 drug resistance in vivo. BBA – Molec. Cell Res. 1803(5): 575-583.
16. Labanauskas, L., Dudutiene, V., Matulis, D., Urbelis, G. 2009. Synthesis of a new heterocyclic system: 3 phenylbenzimidazo[1,2-c]-[1,2,3]selenadiazole. Chem. Heterocycl. Comp. No. 9: 1153-1154.
17. Ugele, M., Sasse, F., Knapp, S., Fedorov, O., Zubriene, A., Matulis, D., Maier, M.E. 2009. Propionate Analogues of Zearalenone Bind to Hsp90. Chembiochem. 4;10(13): 2203-12.
18. Baranauskiene, L., Petrikaite, V., Matuliene, J., Matulis, D. 2009. Titration Calorimetry Standards and the Precision of Isothermal Titration Calorimetry Data. Int. J. Mol. Sci. 10: 2752-2762.
19. Zubriene, A., Matuliene, J., Baranauskiene, L., Jachno, J., Torresan, J., Michailoviene, V., Cimmperman, P., Matulis, D. 2009. Measurement of Nanomolar Dissociation Constants by Titration Calorimetry and Thermal Shift Assay – Radicicol Binding to Hsp90 and Ethoxzolamide Binding to CAII. Int. J. Mol. Sci. 10: 2662-2680.
20. Cikotiene, I., Kazlauskas, E., Matuliene, J., Michailoviene, V., Torresan, J., Jachno, J., Matulis, D. 2009. 5-Aryl-4-(5-substituted-2,4- dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone. Bioorg Med Chem Lett. 19: 1089-1092.
21. Hilvo, M., Baranauskiene, L., Salzano, A.M., Scaloni, A., Matulis, D., Innocenti, A., Scozzafava, A., Monti, S.M., Di Fiore, A., De Simone, G.,  Lindfors, M., Jänis, J., Valjakka, J., Pastoreková, S., Pastorek, J., Kulomaa, M.S., Nordlund, H.R., Supuran, C.T., Parkkila, S. 2008 Biochemical characterization of CA IX: one of the most active carbonic anhydrase isozymes. J Biol Chem. 283: 27799-27809.
22. Cimmperman, P., Baranauskiene, L., Jachimoviciute, S., Jachno, J., Torresan, J., Michailoviene, V., Matuliene, J., Sereikaite, J., Bumelis, V., Matulis, D. 2008. A Quantitative Model of Thermal Stabilization and Destabilization of Proteins by Ligands. Biophys. J. 95: 3222-3231.
23. Baranauskiene, L., Matuliene, J., Matulis, D. 2008. Determination of the thermodynamics of carbonic anhydrase acid-unfolding by titration calorimetry. J. Biochem. Biophys. Meth. 70: 1043­-1047.
24. Dudutiene, V., Baranauskiene, L., Matulis, D., 2007. Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase. Bioorg Med Chem Lett. 17, 3335-3338.
25. Matulis, D., Kranz, J., Salemme, F.R., and Todd, M.J. 2005. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry. 44: 5258-66.
26. Matulis, D., Lovrien, R. 2005. Assays for Total Protein. Current Protocols in Protein Science: 3.4.1-3.4.4. Republished updated version.
27. Matulis, D. and Todd, M. 2004. Thermodynamics – structure correlations of sulfonamide inhibitor binding to carbonic anhydrase. Biocalorimetry 2, eds. Ladbury, J.E. and Doyle, M.L. Wiley. 107-132.
28. Matulis, D., Rouzina, I. and Bloomfield, V. 2002. Thermodynamics of cationic lipid binding to DNA and DNA condensation: Roles of electrostatics and hydrophobicity. J. Am. Chem. Soc. 124: 7331-7342.
29. Lovrien, R., Wu, C., and Matulis, D. 2000. Ligand - protein coprecipitative isolation by matrix stacking and entanglement. Sep. Sci. Technol. 35(11): 1795-1811.
30. Matulis, D., Rouzina, I., and Bloomfield, V. 2000. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. J. Mol. Biol. 296: 1053-1063.
31. Matulis, D., Baumann, C., Bloomfield, V., and Lovrien, R. 1999. 1-Anilino-8-naphthalene sulfonate as a protein conformational tightening agent. Biopol. 49: 451-458.
32. Matulis, D., Wu, C., Pham, T., Guy, C., and, Lovrien, R. 1999. Protection of enzymes by aromatic sulfonates from inactivation by acid and elevated temperatures. J. Molec. Catalysis B: Enzymatic. 7: 21-36.
33. Lovrien, R. and Matulis, D. 1998. Determination of total protein. Current Protocols in Pharmacology. John Wiley and Sons. Appendix.
34. Matulis, D., and Lovrien, R. 1998. 1-Anilino-8-naphthalene sulfonate anion-protein binding depends primarily on ion pair formation. Biophys. J. 74: 422-429.
35. Wu, C., Lovrien, R. and Matulis, D. 1998. Lectin coprecipitative isolation from crudes by little rock orange ligand. Analyt. Biochem. 257: 33-39.
36. Rubikas, J. and Matulis, D. 1998. Nickel resistance in Escherichia coli V38 isolated from city sewage sludge. Ekologija. 9: 24-28.3.
37. Rubikas, J., and Matulis, D. 1998. Nickel ion efflux is the main mechanism of resistance in Escherichia coli V38. Ekologija. 9: 29-32.
38. Matulis, D., Lovrien, R. 1997. Selective Precipitation of Proteins. Current Protocols in Protein Science: 4.5.1-4.5.36.
39. Rubikas, J., Matulis, D., Leipus, A., and Urbaitiene, D. 1997. Nickel resistance in Escherichia Coli V38 is dependent on the concentration used for induction. FEMS Microbiol. Lett. 155: 193-198.
40. Matulis, D., Richardson, T. and Lovrien, R. 1996. Coprecipitation of proteins with matrix ligands: scaleable protein isolation. J. Molec. Recogn. 9: 433-443.
41. Matulis, D., Lovrien, R. 1995. Assays for Total Protein. Current Protocols in Protein Science: 3.4.1-3.4.4.

1. Giessrigl, B., Krieger, S., Rosner, M., Huttary, N., Saiko, Ph., Alami, M., Messaoudi, S., Peyrat, J. F., Maciuk, A., Gollinger, M., Kopf, S., Kazlauskas, E., Mazal, P., Szekeres, T., Hengstschlager, M., Matulis, D., Jager, W., Krupitza, G. 2012. Hsp90 stabilizes Cdc25A and counteracts heat shock-mediated Cdc25A degradation and cell-cycle Q1 attenuation in pancreatic carcinoma cells. Human Molecular Genetics. 21: 4615-4627.

1. Capkauskaite, E., Zubriene , A., Baranauskiene, L., Tamulaitiene, G., Manakova, L., Kairys,  V., Grazulis, S., Tumkevicius, S., Matulis, D. 2012. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases. Eur. J. Med. Chem. 51: 259-270.
2. Norvaisas, P., Petrauskas, V., and Matulis, D. 2012. Thermodynamics of Cationic and Anionic Surfactant Interaction. J. Phys. Chem. B. 116: 2138-2144.
3. Baranauskiene, L., Matulis, D.  2012. Intrinsic thermodynamics of ethoxzolamide inhibitor binding to human carbonic anhydrase XIII. BMC Biophysics. 5:12 2046-1682

1. Zubriene, A., Gutkowska, M., Matuliene, J., Chaleckis, R., Michailoviene, V., Voroncova, A., Venclovas, C., Zylicz, A., Zylicz, M., and Matulis, D. 2010. Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms. Biophys. Chem. 152: 153-163.
2. Rink, C., Sasse, F., Zubriene, A., Matulis, D. and Maier, M. E. 2010. Probing the Influence of an Allylic Methyl Group in Zearalenone Analogues on Binding to Hsp90. Chemistry. A European Journal. 16(48): 14469-78.

1. Matulis, D. 2001. Thermodynamics of the hydrophobic effect. III. Condensation and aggregation of alkanes, alcohols, and alkylamines. Biophys. Chem. 93: 67-82.
2. Matulis, D., and Bloomfield, V. 2001. Thermodynamics of the hydrophobic effect. II. Calorimetric measurement of enthalpy, entropy, and heat capacity of aggregation of alkylamines and long aliphatic chains. Biophys. Chem. 93: 53-65.
3. Matulis, D., and Bloomfield, V. 2001. Thermodynamics of the hydrophobic effect. I. Coupling of aggregation and pKa shifts in solutions of aliphatic amines. Biophys. Chem. 93: 37-51.

Patents

1. European Patent No. 2054420.  “Benzimidazo[1,2-C][1,2,3]Thiadiazol-7-Sulfonamides as Inhibitors of Carbonic Anhydrase and the Intermediates for Production Thereof”. Application submited in 2007, patent registered on 2011 06 22
2. European Patent No. 2268626. “5-Aryl-4-(5-Substituted 2,4-Dihydroxyphenyl)- 1,2,3 Thiadiazoles as Inhibitors of Hsp90 Chaperone and the Intermediates for Production Thereof”. Application submited in 2008, patent registered on 2012 02 01

Patent Application

1. Matulis D., Dudutiene V., Zubriene A.

Fluorinated benzenesulfonamides as inhibitors of Carbonic Anhydrase. PCT/LT2012/000007. 2012-10-30

Other important academic activities

1. Written about 15 articles on the subjects of scientific reform, the popularity of science in society, and the support for repatriating scientists.
2. Participated in several TV programs and radio shows on science popularity and administrative reforms.
3. Member of several work groups at the Ministry of Economy and the Ministry of Science and Education; discussions and preparation of legal documents in science administration.
4. Member of professional societies – American Chemical Society, Biophysical Society, an expert of the ScanBalt projects, mapping of Baltic biotechnology, discussions on  international collaboration of biotechnologists. An expert to the EU FP7 “Health” program committee in Brussels.
5. Member of the ScanBalt task force for the implementation of the EU Baltic Sea strategy

Conference organization

1. „COST TD0905“, 2013 10 30-31, Vilnius, Lithuania.
2. Co-Chairman of CEEC-TAC2 2^nd Central and Eastern European Conference on Thermal Analysis and Calorimetry, 2013 08 27-30, Vilnius, Lithuania.
3. Local Chair and Member of ScanBalt Scientific Advisory Board of the ScanBalt Forum and ScanBalt Biomaterials Days, 2008 09 24-26, Vilnius, Lithuania.

Invited talks at international conferences and organizations

1.      Matulis D. “Biophysical assays of inhibitor binding to selected CA isozymes”. 2nd CA satellite meeting, Naples, Italy. 2013 10 23-25.

2.      Matulis D. “Novel inhibitors of Carbonic Anhydrase IX, an Anticancer Target“.Lithuanian Trade Mission to Boston (and Washington), Boston, USA. 2013 06 16-25.

3.      Matulis D. “Intrinsic thermodynamics – structure correlations of anticancer drug lead binding to target proteins”. “CEEC-TAC2”, Vilnius, Lithuania. 2013 08 27-30.

4.      Matulis D. Intrinsic thermodynamics - structure correlations of anticancer drug lead binding to target proteins.„ 20th Biennial Meeting of the International Society for Molecular Recognition“, Vienna, Austria. 2013 06 26-29. 

5.      Matulis D. Drug Design: Intrinsic Energetics – Structure Correlations,  ITC, TF, Activity, X-ray. „Biophysical Society 57th Annual Meeting”, Philadelphia, USA. 2013 01 31-02 14.

6.      Matulis D. Design, synthesis, binding, crystallography, and docking of [(2-pyrimidinylthio)acetyl] benzenesulfonamides as inhibitors of human carbonic anhydrases. „COST0804“, Salerno, Italy. 2012 11 03-07.

7.      Matulis D. Overview of Lithuanian Pharmaceutical Industry. „Life Sciences Baltics Conference“. Vilnius, Lithuania. 2012 09 12-14.

8.      Matulis D.  Thermodynamics Of Inhibitor Binding To Recombinant Human Carbonic Anhydrases (CA) VI and XII. „Future in Chemistry and Biology for Epigenetics training school“. Poitiers, France. 2012 07 09-12

9.      Matulis, D. Structural biothermodynamics of inhibitor binding to human recombinant carbonic anhydrases and Hsp90.  Presented at the “66th Calorimetry Conference”. Honolulu, USA. 2011 06 14.

10.  Matulis, D. Carbonic anhydrase inhibitors as anticancer agents. Moletai, Lithuania. 2010 06 16.

1. Matulis, D. Structural biothermodynamics and the search for drug-like compounds. Plenary lecture given at the Institute of Theoretical Physics and Astronomy of Vilnius university, Moletai Astronomical Observatory, Moletai, Lithuania. 2010 07 31.
2. Matulis, D. Structural biothermodynamics and the search for drug-like compounds. Plenary lecture given at the Conference of Organic Synthesis, Kaunas University of Technology, Kaunas, Lithuania. 2009 04 22.
3. Matulis, D. Carbonic anhydrase and Hsp90 inhibitor binding measurements by TSA, ITC, and X-ray crystallography. Instruct meeting. Budapest, Hungary. 2009 03 30.
4. Matulis, D. Characterization of carbonic anhydrases and determination of inhibitor binding by thermal shift assay. Invited by Prof. Seppo Parkkila, Institute of Medical Technology / University of Tampere, Biokatu 6, 33520 Tampere, Finland. 2007 11 19.
5. Matulis, D. Characterization of carbonic anhydrases and determination of inhibitor binding by thermal shift assay. Invited by Prof. Claudiu Supuran, Universita Degli Studi Di Firenze, Dipartimento Di Chimica, Italy. 2007 11 23.
6. Matulis, D. Human Hsp90 stability and radicicol binding by thermal shift assay. Invited by Prof. Maciej Zylicz, International Institute of Molecular and Cell Biology in Warshaw, Poland. 2006 12 15.
7. Matulis, D., and Todd, M. Thermodynamics of sulfonamide inhibitor binding to carbonic anhydrase using titration calorimetry: an interesting effect of protein, ligand, and buffer protonation. Presented at the 2003 Current Trends in Microcalorimetry, Boston, USA. 2003 07.
8. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the Nucleic Acid Interest Group, University of Minnesota. 1999 11.
9. Matulis, D. Using isothermal titration calorimetry to evaluate the energetics of intermolecular interactions. Presented at the Nucleic Acid Interest Group, University of Minnesota. 1998 03.

Talks given at conferences and meetings

1.      Matulis D. „ExCo meeting“. 2013 06 03 – 04 . Rostock, Germany.

2.      Matulis D. “The Pitfalls of Drug Lead IC 50 and Binding Measurements to Target Proteins”. „COST CM0804“. 2013 05 06-09, Izmir, Turkey.

3.      Matulis, D., Budvytyte, R., Cerniauskaite, D. 11th ScanBalt Forum. 2012 11 20 – 23. Tampere, Finland.

4.      Matulis, D., Budvytyte, R. „ExCo meeting“. 2012 08 28. Copenhagen, Denmark.

5.      Matulis, D. Thiophene Sulfonamides as Carbonic Anhydrase Inhibitors by Titration Calorimetry and Thermal Shift Assay. COST TD 0905, Latvia, Riga. 2012 06 26-28. 

6.      Matulis, D. Anticancer activity of ICPD inhibitors of Hsp90 on human tumor cell lines and in murine tumor allografts. „COST0804“, Bucuresti, Romania. 2012 05 20-24.

7.      Blank, W., Matulis, D., Frank, P. ScanBalt Health Region – Setting the Stage for Cross-Sectorial Innovation in Health and Life Sciences. What is in for the regions? Baltic Development Forum. 2011 10 25 – 27. Gdansk, Poland.

8.      Matulis, D., Grinius, L., Revuckiene, J., Budvytyte, R., Cerniauskaite, D. „BSHR HealthPort“ project meeting. 10th ScanBalt Forum. 2011 09 21 – 24. Heringsdorf, Germany.

1. Matulis, D. Structural biothermodynamics of inhibitor binding to human recombinant carbonic anhydrases. “FEBS satellite CA meeting”. Montecatini, Italy. 2011 06 22-24.  
2. Zubriene, A., Kazlauskas E., Baranauskiene, L., Petrauskas, V., Matulis, D. Towards the intrinsic lead binding thermodynamics.  COST TD 0905. Split, Croatia. 2011 04 28-05 01.
3. Matulis, D. Determination of the Volume Changes Induced by Ligand Binding to Hsp90 Using High Pressure Denaturation. Biophysical Society 55th Annual Meeting. Baltimore, USA. 2011 03 05-09.
4. Matulis, D. Structural biothermodynamics of inhibitor binding to human recombinant carbonic anhydrases and Hsp90. Johnson & Johnson. USA. 2011 03 10.
5. Toleikis,  Z., Cimmperman, P., and Matulis, D. The Volumes of Ligand Binding to Hsp90 by High Pressure Denaturation. The 6th International Conference on High Pressure Bioscience and Biotechnology (HPBB2010). Munich, Germany. 2010 08 28-09 01.
6. Zubriene, A., Matulis, D. Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms. ESBES+ISPPP+ISB. Bologna, Italy. 2010 09 05-08.
7. Zubriene, A., Maier, E.M., Sasse, F., Kazlauskas, E., Toleikis, Z., Chaleckis, R., Michaoloviene, V., Petrikaite, V., Grinius, L., Matuliene, J., Matulis, D. Radicicol, a natural compound and an efficient inhibitor of Hsp90, as a lead for anticancer drug design. COST CM0804, “Natural Products as Drug and Leads to Drugs”. Crete, Greece. 2010 10 12-15.
8. Zubriene, A., Baranauskiene, L., Kazlauskas, E., Toleikis, Z., Chaleckis, R., Michailoviene, V., Petrikaite, V., Capkauskaite, E., Dudutiene, V., Matuliene, J., Matulis, D. Drug Binding Energetics by Titration Calorimetry, Thermal and Pressure Shift Assay. COST Action TD09/05 Epigenetics - Bench to Bedside. Brno, Czechia. 2010 11 22-25.
9. Baranauskiene, L., Kazlauskas, E., Cikotiene, I., Matuliene, J., Zubiene, A., Jachno, J., Torresan, J., Michailoviene, V., Cimmperman, P., Grazulis, S., and Matulis D. Carbonic anhydrase and Hsp90 inhibitor binding measurements by thermal shift assay, titration calorimetry, and x-ray crystallography. INSTRUCT meeting. Budapest, Hungary. 2009 03 29-31.
10. Baranauskiene, L., Sudzius, J., Michailoviene, V.,  Matuliene, J., Tumkevicius, S., Matulis, D. Carbonic anhydrase ligand binding by thermal shift assay and titration calorimetry. The 8-th International Conference on the Carbonic Anhydrases. Florence, Italy. 2009 09 16-19.
11. Cimmperman, P., Zubriene, A., Baranauskiene, L., Kazlauskas, E., Matuliene, J., and Matulis, D. Determination of protein-ligand binding thermodynamics by thermal shift assay. European Biophysics Congress Genova. Genova, Italy .2009 07 11-15.
12. Petrikaite, V., and Matulis, D. Thermal Shift Assay and Titration Calorimetry for Protein-Ligand Interactions. COST CM0804 Conference “Chemical Biology with Natural Products. Siena, Italy. 2009 12 3-5.
13. Kazlauskas, E., Cikotiene, I., Matuliene, J., Zubriene, A., Jachno, J., Torresan, J., Michailoviene, V., Matulis, D. Resorcinol class Hsp90 inhibitor binding thermodynamics and the effect on cancerous cells. The 4^th International Conference on the Hsp90 Chaperone Machine. Bavaria, Germany. 2008 10 2-6.
14. Baranauskiene, L., Dudutiene, V., Matulis, D. Benzimidazo [1,2-c][1,2,3] thiadiazole sulfonamides as carboinic anhydrase inhibitors. 7th International Conference on Carbonic Anhydrases: CA Research in the Postgenomic Era. Whitney Laboratory of the University of Florida, St. Augustine, USA. 2006.

1. Matulis, D., and Todd, M. A. Thermodynamics of sulfonamide inhibitor binding to carbonic anhydrase using titration calorimetry: and interesting effect of protein, ligand, and buffer protonation. Presented at the 58^th Calorimetry Conference, Honolulu, USA. 2003 08.
2. Matulis, D., and Bloomfield, V. Determination of hydrophobic interactions between long aliphatic hydrocarbons: aliphatic amine aggregtion and protonation pKa shift. Presented at the 15^th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 2001 09.
3. Matulis, D., and Bloomfield, V. Determination of hydrophobic interactions between long aliphatic hydrocarbons: aliphatic amine aggregtion and protonation pKa shift. Presented at the 56^th Annual Calorimetry Conference, Colorado Springs, USA. 2001 08.
4. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of cationic lipid binding to DNA by isothermal titration calorimetry. The roles of electrostatics and hydrophobicity. Presented at the 14^th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 2000 05.
5. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of cationic lipid binding to DNA by isothermal titration calorimetry. The roles of electrostatics and hydrophobicity. Presented at 2000 Midwest Thermodynamics and Statistical Mechanics Conference, Minneapolis, USA. 2000 05.
6. Matulis, D., and Lovrien, R. Protection of enzymes by aromatic sulfonates from inactivation by acid. Presented at the First International Conference on Protein Stabilization, Leeds, Great Britain. 1998 07.
7. Matulis, D., and Lovrien, R. ANS anion - protein binding primarily depends on ion pair formation. Given at the 42^nd Annual Meeting of the Biophysical Society, Kansas City, USA. 1998 02.

Poster Presentations at Meetings and Conferences

1.      Gylyte, J., Zubriene, A., Dudutiene, V., Smirnov, A., Timm, D., Manakova, E., Grazulis, S., Matulis, D. „Intrinsic thermodynamics-structure correlations of fluorinated benzensulfonamides as inhibitors of human carbonic anhydrases“. „The Twenty-seventh Annual Gibbs Conference on Biothermodynamics”, 2013 10 05-08, Carbondale, USA.

2.      Petrauskas, V., Gylyte, J., Toleikis, Z., Cimmperman, P., Matulis, D. „Protein-ligand affinity correlation with the ligand binding volume“. „9th European Biophysics Congress“, 2013 07 13-18, Lisbon, Portugal. 

3.      Petrikaite, V., Matuliene, J., Tauraite, D., Villanueva, A., Berdasco, M., Huertas, A., Satein, E. F., Esteller, M., Matulis, D. „Anticancer activity of ICPD compounds in murine models and human cancer cells”. „COST TD0905“, 2013 04 29-30, Reykjavik, Iceland.

4.      Kazlauskas, E., CikotienE, I.,  ZubrienE, A., Matuliene, J., Mikuciauskaite, J., Chaleckis, R., Sharp S., Workman P., Prodromou, Ch, Matulis, D. “ICPD Inhibitor Binding to Human Hsp90 alpha, beta, Full-Length, N-Terminal Domain, Lidless, and Active Site Mutant Isoforms”. „6th International Conference on the Hsp90 Chaperone Machine”, 2012 09 19-23, Les Diablerets, Šveicarija.

5.      Norvaišas P., Petrauskas V., Matulis D. “Thermodynamics of cationic and anionic surfactant interaction”. “XVII International Society of Biological Calorimetry (ISBC) Conference“. Leipzig, Germany. 2012 06 03-06.

6.      Capkauskaite E., Zubriene A., Baranauskiene L., Manakova E., Tamulaitiene G., Kazokaite J., Kairys V., Grazulis S., Tumkevicius S., Matulis D. „Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases“. „The 9th International Conference on Carbonic Anhydrase (CA)“. Turkey, Antalya. 2012 04 11-15.

1. Capkauskaite, E., Zubriene, A., Baranauskiene, L., Tamulaitiene, G., Manakova, E., Grazulis, S., Tumkevicius, S., Matulis, D. Synthesis of pyrimidine derivatives as inhibitors of carbonic anhydrase. 23rd International Congress on Heterocyclic Chemistry (ICHC-23). Glasgow, Great Britain. 2011 07 31-08 04
2. Petrikaite, V., Kazlauskas, E., Matuliene, J., Matulis, D. Anticancer activity and Admet properties of resorcinol – bearing lead compounds. The 47th International Conference „Drug Discovery and Selection“. Lyon, France. 2011 07 06-08
3. Dudutiene, V, Zubriene, A., Kairys, V., Matulis, D. Probing of the carbonic anhydrase isozyme active center cavities with inhibitor functional groups. International Conference „Frontiers in Medicinal Chemistry“. Stocholm, Sweden. 2011 06 19-21.
4. Petrauskas, V., Zubriene, A., Kazlauskas, E., Baranauskiene, L., Matulis, D. Intrinsic Binding Parameters as a Necessity to Correlate Energetics with Structure. 19th Biennial Meeting of the International Society for Molecular Recognition. Tavira, Portugal. 2011 06 16-19.
5. Jogaite, V., Zubriene, A., Gylyte, J., Michailoviene, V., Matulis, D. Inhibitors binding to Recombinant Human CAXII. „FEBS satellite CA meeting“. Montecatini, Italy. 2011 06 22-24.

12.  Matulis, D. Carbonic anhydrase inhibitors as anticancer agents. Moletai, Lithuania. 2010 06 16.

13.  Toleikis,  Z., Cimmperman, P., and Matulis, D. Determination of The Volume Changes Induced by Ligand Binding to Hsp90 Using High Pressure Denaturation. The 6th International Conference on High Pressure Bioscience and Biotechnology (HPBB2010). Munich,  Germany. 2010 08 28-09 01.

14.  Petrauskas, V., Maksimaviciute, E., Matulis, D. Thermodynamics of Ion Pair Formations in Proteins. ESBES+ISPPP+ISB. Bologna, Italy. 2010 09 05-08.

1. Zubriene, A., Kazlauskas, E., Chaleckis, R., Michailoviene, V., Matuliene, J., Matulis, D. Thermodynamics of radicicol binding to human Hsp90 alpha and beta isoforms. The 5th International Conference on The Hsp90 Chaperone Machine. Les Diablerets, Switzerland. 2010 09 29-10 03.
2. Petrikaite, V., Kazlauskas, E., Zubriene, A., Michailoviene, V., Matuliene, J., Matulis, D. Resorcinol -  Bearing Hsp90 inhibitors as anticancer agents. COST Action TD09/05 Epigenetics - Bench to Bedside. Brno, Czechia. 2010 11 22-25
3. Kazlauskas, E., Cikotiene, I., Matuliene, J., Zubriene, A., Jachno, J., Torresan, J., Michailoviene, V., Petrikaite, V., Grinius, L., Matulis, D. Resorcinol class Hsp90 inhibitor binding thermodynamics and the effect on cancerous cells. The 4^th International Conference on the Hsp90 Chaperone Machine. Bavaria, Germany. 2008 10 2-6.
4. S. Grazulis, L. Baranauskiene, E. Manakova, R. Sukackaite, D. Golovenko, G. Tamulaitiene, D. Matulis. Novel thiadiazoles inhibitors of human carbonic anhydrases. 7th ScanBalt Forum & Biomaterial Days. Vilnius, Lithuania. 2008 09 24-26.

19.  S. Grazulis, L. Baranauskiene, E. Manakova, R. Sukackaite, D. Golovenko, G. Tamulaitiene, D. Matulis. Novel thiadiazoles inhibitors of human carbonic anhydrases. XXI Congress and General Assembly of the International Union of Crystallography. Osaka, Japan.  2008 08 23-31.

1. Cimmperman, P., Toleikis, Z., Matulis, D. A general model to describe protein thermal stabilization and destabilization by ligands. 2^nd International Symposium on Biothermodynamics, Frankfurt am Main, Germany.  2008 02 21-22.
2. Matulis, D., and Todd, M. Thermodynamics of inhibitor binding to carbonic anhydrase by titration calorimetry and ThermoFluor®. Presented at the 16^th Gibbs Conference on Biothermodynamics, Carbondale, USA. 2002 09.
3. Matulis, D., and Todd, M. Thermodynamics of inhibitor binding to carbonic anhydrase by titration calorimetry and ThermoFluor®. Presented at the 57^th Annual Calorimetry Conference, New Brunswick, USA. 2002 08.
4. Matulis, D., Rouzina, I., and Bloomfield, V. Determination of hydrophobic interactions between long chain aliphatic hydrocarbons by titration calorimetry. Presented at the 46^th Annual Meeting of the Biophysical Society, San Francisco, USA. 2002 02.
5. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics cationic lipid binding to DNA by titration calorimetry: the roles of electrostatics and hydrophobicity. Presented at the 45^th Annual Meeting of the Biophysical Society, Boston, USA. 2001 02.
6. Lovrien, R., Wu, C., and Matulis, D. Lectin and protease isolation from crude via coprecipitation matrix ligands. Presented at the American Chemical Society 219th National Meeting, San Francisco, USA. 2000 03.
7. Lovrien, R. and Matulis, D.. Isolation of proteins from crudes: Matrix entanglement ligand basis.  Presented at the American Chemical Society 219th National Meeting, San Francisco, USA. 2000 03.
8. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the 44^th Annual Meeting of the Biophysical Society, New Orleans, USA. 2000 02.
9. Lovrien, R., Wu, C., and Matulis, D. Forces, energetics, topology of outer directed hydrophobicity in organic ligand-protein matrices. Presented at the 44^th Annual Meeting of the Biophysical Society, New Orleans, USA. 2000 02.
10. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the Nucleic Acid Interest Group meeting. 1999 10.
11. Matulis, D., Rouzina, I., and Bloomfield, V. Thermodynamics of DNA binding and condensation: isothermal titration calorimetry and electrostatic mechanism. Presented at the 13^th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 1999 10.
12. Matulis, D., and Lovrien, R. Prediction of free energies and enthalpies of anionic aliphatic ligand binding to proteins based on experimental database and the enthalpy additivity principle. Presented at the 43^rd Annual Meeting of the Biophysical Society, Baltimore, USA. 1999 02.
13. Lovrien, R., and Matulis, D. Pushing agents, pulling agents in protein isolation. Presented at the 43^rd Annual Meeting of the Biophysical Society, Baltimore, USA. 1999 02.
14. Matulis, D., and Lovrien, R. Thermodynamics of the organic and inorganic anion binding to the strongest site on bovine serum albumin. Presented at the 12^th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 1998 10.
15. Matulis, D., and Lovrien, R. Protection of enzymes by aromatic sulfonates from inactivation by acid. Presented at the First International Conference on Protein Stabilization, Leeds, Great Britain. 1998 06.
16. Matulis, D., and Lovrien, R. ANS anion - protein binding primarily depends on ion pair formation. Presented at the 11^th Annual Gibbs Conference on Biothermodynamics, Carbondale, USA. 1997 10.
17. Matulis, D., and Lovrien, R. Alkane sulfates (SDS) bind to proteins by forming ion pairs with the positively charged amino acids. Presented at the 3^rd International Conference on Lipid-Binding Proteins, Minneapolis, USA. 1997 05.
18. Matulis, D., Wu, C., and Lovrien, R. Designing pushing, pulling, hybrid push-pull agents for protein precipitation. Presented at the 41^st Annual Meeting of the Biophysical Society, New Orleans, USA. 1997 02.
19. Lovrien, R., and Matulis, D. Biophysical perspectives on protein precipitation-coprecipitation. Presented at the 40^th Annual Meeting of the Biophysical Society, Baltimore, USA. 1996 02.
20. Lovrien, R. and Matulis, D. Hard and soft sulfate and sulfonate anions in protein precipitation-biorecognition. Presented at the 39^th Annual Meeting of the Biophysical Society, San Francisco, USA. 1995 02.
21.  Matulis, D., Meškys, R., and Rubikas, J. Removal of nickel from industrial effluents: an innovative process using the bacterial membrane transport system for nickel. Presented at the Fourth International Symposium on Biological Processing of Fossil Fuels, Alghero, Italy. 1993 09.
22. Matulis, D., Meškys, R., and Rubikas, J. Nickel uptake and efflux by bacterial cells. Presented at the International Symposium on Biological Processing of Fossil Fuel in Moscow, Russia. 1991 09.

Academic research projects

1. VP1-3.1-ŠMM-07-K-009 „Support to Research Activities of Scientists and Other Researcher (Global Grant)“. “Design of selective carbonic anhydrase, Hsp90, and Hsp70 inhibitors and investigation of their anticancer properties”. (405 454 €), 2012 09 02 – 2015 10 01.
2. Grant No. LIG-09/2012 from the Research Council of Lithuania. (171 021 €), 2012 05 02 – 2014 12 31.
3. “BPS Mini-Grant Networking Event”. (380 €), 2012.
4. Baltic Sea Region Programme 2007 – 2013. Baltic Sea Health Region – Business acceleration support and training bridging innovative SMEs and health care organisations to strengthen BSR health economy, BSHR HealthPort. (111 000 €), 2010 09 17 - 2013 12 16.
5. FP7-REGPOT-2009-1 MoBiLi   "Strengthening  and  sustaining  the  European perspectives  of  Molecular Biotechnology  in  Lithuania".  (1 600 000 €), 2009 12 – 2013 05.
6. Grant No. LIG-16/2010 from the Research Council of Lithuania. (294 800 €), 2010 09 – 2011 12.
7. Epigenetics: Bench to Bedside. COST. 2009 – 2013.
8. Chemical Biology with natural products. COST. 2009.
9. Anticancer drug design by structural biothermodynamics“ by EEA-Norway Grants (565 037 €), 2008 – 2010.
10. “Design of specific human carbonic anhydrase inhibitors”, by the Lithuanian Science and Studies Foundation, (362 000 €), 2005 – 2009.
11. “Drug design by structural thermodynamics”, European Union FP6 Marie Curie international reintegration grant, (80 000 €), 2004 – 2006.

Former Yugoslavian Republic of Macedonia

Dijana Plaseska-Karanfilska

Prof Dijana Plaseska-Karanfilska graduated from the Medical School in Skopje, Republic of Macedonia in 1987. She received her PhD from the Medical Faculty, Limburg University, Maastricht, the Netherlands in 1994. She has been employed at the Research Centre for Genetic Engineering and Biotechnology (RCGEB) “Georgi D. Efremov”,Macedonian Academy of Sciences and Arts (MASA) since 1988, where currently she holds a position of senior scientist and Head of the laboratories. Since 2010 she is a professor at the “St. Cyril and Methodius”, Skopje, R. Macedonia and is involved in undergraduate, master and PhD studies at the Faculties of Pharmacy and Natural Sciences.

She has made significant contribution to the molecular characterization of different monogenic diseases in the Republic of Macedonia. She has been engaged in the molecular diagnostics of inherited, malignant and infectious diseases and has contributed to the translation of a number of molecular genetic tests to clinical practice.

She was coordinating the FP7 REGPOT project, entitled “National Reference Centre for Genomics and Proteomics - MACPROGEN”, financed by the European Commission in the period from April 2009 to June 2012. This project has enabled establishment of a technological platform for high throughput genomics and proteomics research in Macedonia and has resulted in strengthening of national and regional research capacities in these fields. Her recent research interest focuses in reproductive genetics, such as male infertility, spontaneous abortion, rapid and non-invasive prenatal diagnosis and breast cancer.

EBTNA Representative in Mexico

Karla Santacruz-Gomez

Professor Santacruz graduated in Chemical Biology in 2007 from the University of Sonora in Mexico. She received a specialization in Immunohematology and a Master's Degree in Health Sciences. In 2013, she obtained a PhD from the Centro de Investigación de Materiales Avanzados and Universidad Autónoma de Madrid in Spain. In 2015, she performed a postdoctoral fellowship at the University of California San Diego.

She works as a full-time professor at the Universidad de Sonora in Mexico. Additionally, she holds key leadership position as a women in STEM mentorship, President of the Research Ethics Committee, Coordinator of academic engagement and chairperson of the Departmental Board of Physics. Her research interests are focused on Radiobiology and nanobiomedicine, focusing the synthesis and characterization of nanomaterials for breast cancer detection and treatment.

She serves as a reviewer for multiple journals and has authored numerous publications. She is an active speaker at conferences in the fields of nanomaterials, physics, and biology. Furthermore, she has successfully supervised undergraduate, master's, and doctoral theses. In recognition of her exceptional achievements, Professor Santacruz was honored with an honoris causa doctorate from the International Organization for Inclusive Education in 2022.

EBTNA Representative in Moldova

Serghei Sprincean

Dr. Serghei Sprincean is Associate Professor of Bioethics at State University of Medicine and Pharmacy "Nicolae Testemitanu", Chisinau, Republic of Moldova, coordinator of Master Program in National Security at University of Academy of Science of Moldova and Senior Researcher of department of Political Science of the Institute of European Integration and Political Science of Academy of Sciences of Moldova.

Current research interests: Social and political aspects of bioethical issues, improvement of activity of ethical committees in the field of regulation and monitoring of social and biomedical research, enhancement and development of bioethical capacity in developing and low income countries, importance of social and professional interest groups in promoting bioethical values and principles, bioethics as an ideology of public health, political bioethics.

EBTNA Represantative in Netherlands

Mark Nuijten

Dr. Mark Nuijten trained as a physician and worked in clinical practice before obtaining an international M.B.A. from Erasmus University, Rotterdam, with a focuson financial management. He obtained his PhD in health economics (2003) on the thesis “In search of more confidence in health economic modelling” at the Erasmus University, Rotterdam. Dr. Nuijten has become one of the top health economic experts over the last decade, reflected in more than 180 publications and leading positions in scientific societies and editorial boards. Dr. Nuijten was Board Director of ISPOR (2002-2004) and Chair of the Management Board of Value in Health (2002-2004). He was member of the Editorial Advisory Board of Value in Health. Dr. Nuijtenis internationally renowned for achievements in mathematical modelling, also reflected in many publications and positive reimbursement decisions in many markets for innovative medications by institutions, like NICE in England.

He is a pioneer in the field of healthcare innovation in biotechnology and nutrition, and has been the first classical health economist successfully applying and developing sales forecast methodologies for valuation of biotechnology companies. For example, developing a Pricing Matrix Model for research in early phase development and a Financial Valuation Algorithm for the assessment of the future sales of a new, innovative medicinal product.

Dr Nuijten is pursuing development of economic modelling and broadening its application in health care and finance. His models successfully contributed to positive reimbursement decisions by health authorities in many countries, (for example, SMC in Scotland, TLV in Sweden, and The National Health   Care Institute in The Netherlands).

He is academic supervisor of PhD programs at the Universities of Maastricht and Groningen in The Netherlands and founder of the ISPOR Special Interest Group on nutrition-economics.

Dr. Nuijten owns and runs A2M (Ars Accessus Medica - http://a2m.nl/), whichprovides international consulting services in health economics, pricing, market access and valuation in biotechnology. A2M is a partner of Minerva, an international health economics consortium. A2M established other global collaborations with key opinion formers in key European markets, the US, Canada and Japan. A2M is comfortable with multi-country projects. The current A2M project portfolio reflects its long-time international coverage with health economic models being developed for Russia, Italy, Mexico, UK, France, Netherlands and Belgium.

Prior to setting up A2M, Dr. Nuijten was a partner with MEDTAP International. As a VP Business Development for Europe he established global Pricing and Reimbursement Consultancy Services for MEDTAP. Before MEDTAP, Dr. Nuijten was a Managing Director of the Quintiles office in the Netherlands.
Selected publications bridging health economics, pricing, market access and valuation

Fugel HJ, Nuijten M, Postma M. Economic viability of Stratified Medicine concepts: An investor perspective on drivers and conditions that favour using Stratified Medicine approaches in a cost-contained healthcare environment.

N Biotechnol. 2016 Dec 25;33(6):860-867. doi: 10.1016/j.nbt.2016.09.00

Mark Nuijten. The Potential Impact of Current and Future Pharmaceutical Policy Changes on Cash Flows for Innovative Medicines. The Journal of Private Equity Vol. 18, No. 1 (WINTER 2014), pp. 34-45

Mark Nuijten, Marja Pronk. Financial Valuation Algorithm for the Assessment?of the Future Sales of a New, Innovative Medicinal Product. The Journal of Private Equity. Summer 2014, Vol. 17, No. 3: pp. 35-44. DOI: 10.3905/jpe

Mark Nuijten. Pitfalls in the Valuation of a Pharmaceutical Company. Journal of Private Equity. Fall 2013, Vol. 16, No. 4: pp. 57–66

Fugel HJ, Nuijten M, Faulkner E. The application of economics concepts to stratified medicine--use of health economics data to support market access for stratified medicine interventions. J Med Econ. 2014 May;17(5):305-11.

Walzer S, Nuijten M, Wiesner C, Kaier K, Johansson PO, Oertel S. Microeconomic surplus in health care: applied economic theory in health care in four European countries. Front Pharmacol. 2013 Feb 18;4:17.

Fugel HJ, Nuijten M, Postma M. Stratified medicine and reimbursement issues. Front Pharmacol. 2012;3:181.

Nuijten MJ, Dubois DJ. Cost-utility analysis: current methodological issues and future perspectives. Front Pharmacol 2011; 2 (1-5): 29.

Nuijten MJ, Van Gelder PH. Concise Equation That Captures the Essential Elements of One-Way Sensitivity Analyses in Health Economic Models. Med Decis Making 2011; 642-649.

Nuijten MJ, Mittendorf T, Persson U. Practical issues in handling data input and uncertainty in a budget impact analysis. Eur J Health Econ 2010; 231-241.

Mittendorf T, Briggs A, Bastida J L, Nuijten M & Persson U. Do Health Politicians Really Listen to Health Economists? - Observations from Europe. ISPOR Connections November/December 2009; 15(6): 15-16

Mauskopf JA, Sullivan SD, Caro J, Mullins CD, Nuijten M,  J, Trueman P. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.Value Health. 2007 Sep-Oct;10(5):336-47.

Nuijten MJ. Pricing matrix model: dealing with uncertainty. Eur J Health Econ. 2007 Dec;8(4):333-7.

Nuijten MJC, Kosa J Pricing of Pharmaceuticals. Assessing the Pricing Potential by a Pricing Matrix Model. Eur J Health Econom 2004; 5:110-115. 

Nuijten MJC. The Application of Free Market Theory to the Health Care Market. Eurohealth Winter 2003/2004; 9(4):13-17.

Nuijten MJC, Kosa J, Engelfriet P. Modeling the Cost-Effectiveness and Budgetary Impact for Subpopulations. European Journal of Health Economics 2003; 4:70-78. 

Nuijten MJC and Rutten F. Combining a Budgetary Impact Analysis and a Cost-Effectiveness Analysis Using Decision Analytic Modelling Techniques. PharmacoEconomics 2002;20(12):855-67.

EBTNA Representative in Norway

PERSONAL INFORMATION

*Family name, First name:        Greiner-Tollersrud, Ole Kristian

*Date of birth: 05051956

*Sex: Male

*Nationality: Norwegian

*EDUCATION

1987                PhD:1987 Department of Biochemistry, University of Oslo, Norway

*CURRENT AND PREVIOUS POSITIONS

1999-present   Professor

                        Institute of Medical Biology, University of Tromsø, Norway

1992-1999       Associate professor

                        Institute of Medical Biology, Health Faculty, University of Tromsø, Norway

1991-1992       Senior Researcher

                        National Public Health Institute, Helsinki, Finland

1987-1990       Post Doctor

                        Department of Biochemistry, Penn State University, State College, U.S.A.

MOBILITY

1999-2000       Visiting professor

                        Department of Glycobiology, University of Lille1, France

ORGANISATION OF SCIENTIFIC MEETINGS

2005                Head of organizing committee, 15^th ESGLD workshop, Oslo, Norway 

2016                Member of organizing committee, 51^th NBS contact meeting, Tromsø, Norway 

Scientific interest:

                        Characterization of lysosomal proteins and enzyme replacement therapy of lysosomal protein deficiencies, with a current focus on DADA2 (Deficiency of adenosine deaminase 2)

Publications

The total number of publications: 31

Patent(s):

Patent US6197507, PCT/GB1997/000109 - Genetic test for α-mannosidosis (1997)

Two patent applications on the diagnosis and therapy of DADA2

Research expeditions:

2001-2004            Coordinator of an R&D project (QLK-3-CT-2001-02348), with eight international partners on “A systematic and multidisciplinary approach towards understanding and therapy of the lysosomal storage disorder alpha-mannosidosis”.

EBTNA Represantative in Pakistan

Attya Bhatti

HoD Healthcare Biotechnology ASAB

Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences & Technology (NUST) Sector H-12, Islamabad, Pakistan

Email: attyabhatti@asab.nust.edu.pk, attyabhatti@gmail.com

Dr. Bhatti is a Human Molecular Geneticist and working as an assistant professor at NUST. She directs an immunogenetics molecular laboratory. She is also Head of Department Healthcare Biotechnology. Dr. Bhatti received her PhD degree in Human Molecular Genetics from the Quaid-e-Azam University, Pakistan in 2007. She is young scientist and has ~9 years of experience working on the molecular genetics of common diseases of public health importance, including coronary artery disease, diabetes type 2, and arthritis.  She has published more than 40 scientific research articles with IF of more than 80 and her team has contributed in the identification of several genes for T2D and rheumatoid arthritis. She has received more than 06 R& D grants and published two book chapters.

 She has been supervised/completed the thesis/dissertation work of many PhD, MS, BS students. Dr Bhatti is also the Founding Editor of NUST Journal of Natural Sciences (ISSN: 2072-46592, 2010-Present).

Our research lab contributes not only toward the enhanced understanding about the functional biology of genetic disorders, but also helps in the field of diagnostic and developments of therapies. The lab is mainly focused on investigation of susceptibility genes that influence important human traits responsible for immunological genetic diseases like rheumatoid arthritis, diabetes type 1 & 2 etc. Overall objective is to understand genetic controls of hereditary diseases, especially those which are specific to immune disorders, and how they may control gene expression. 

EBTNA Representative in Poland

Ewa Lojkowska

lojkowska@biotech.ug.gda.pl

EBTNA Representative in Portugal

Isabel Belo

Isabel Belo concluded the Graduation in Chemical Engineering at University of Porto, Portugal, and concluded the PhD in 2000 in Chemical and Biological Engineering at University of Minho, Braga, Portugal. She is Assistant Professor at the Biological Engineering Department of Engineering School of University of Minho where she collaborates in several Graduation and Master Degrees in Biological and Biomedical Engineering and in Biotechnology. She is a staff researcher of the Centre of Biological Engineering-CEB, belonging to the Biosystems group (https://www.ceb.uminho.pt/biosystems). Isabel Belo is the Director of the Bioprocess and Biosystems Laboratory of CEB and is the Director of the Doctoral Program of Chemical and Biological Engineering of University of Minho. Her main research activities are related to Bioprocess Engineering, particularly bioprocesses development and optimization and fermentation technologies. She supervised 7 Post-Doc researchers, 9 PhD thesis concluded and more than 40 Master students. She participated and coordinated several scientific projects with external financial support. She has published 3 book chapters and 67 articles in scientific international journals with peer reviewing and she is associate editor of scientific journals.

EBTNA Representative in Romania

Dana Tapaloaga

Dr. Dana Tapaloaga is Full Professor at the Faculty of Veterinary Medicine, Bucharest. She took her PhD in Veterinary Medicine in 2004 in the field of Animal Reproduction Biotechnology, and her MSc in 1999 (Reproduction Bio Techniques and Biotechnologies) and 1996 (Milk production, processing and trading).

Professional teaching experience area: Milk and meat obtaining technologies, Animal Production Systems, Animal Genetics, Animal breeding.

Current Research interests:  laboratory and economic efficiency researches on bull, buffalo and boar semen; computerized studies on bull and boar semen; laboratory technologies for reproduction biotechnology in breeds preserving; morphologic and hormonal modifications in cows with puerperal disorders; certification and preserving the genetic potential in Mangalitza breed by biotechnological methods.

She was a postdoctoral researcher in the field of animal biodiversity at Postdoctoral School for Animal Sciences Biodiversity and Food Sciences Biotechnologies based upon eco economy and bio economy required to eco san genesis at Romanian Academy, member of Romanian Animal Science Association, member of World Poultry Science Association, member of DAGENE (International Association for the Conservation of Animal Breeds in the Danube Region), member of the Academy of Romanian Scientists, the Committee of National Food Security.

EBTNA Representative in Russia

Victor Revin

Surname: Revin,
Name: Victor
Date of Birth: April 12, 1950.
Position: Head of the Department of Biotechnology, Bioengineering and Biochemistry, Dean of the Faculty of Biotechnology and Biology Ogarev Mordovia State University.
Registered address: Bolshevistskaya Str., 68, Saransk 430005, Republic of Mordovia, Russia
Mobile phone: +7 (927) 2760275
E-mail: revinvv2010@yandex.ru

Career

1. 1977-1997 Head of the Interdepartmental Laboratory of Biophysics, Biological Faculty Ogarev Mordovia State University
2 . 1991 - present - Dean of the Faculty of Biotechnology and Biology ( before 05/07/2014 - Faculty of Biology ) Ogarev Mordovia State University.
3 . 1992 - present Head of the Department of Biotechnology, Bioengineering and Biochemistry, Dean of the Faculty of Biotechnology and Biology Ogarev Mordovia State University

Education and qualifications

1972 Biologist , Ogarev Mordovia State University, Saransk
1977 PhD in Biological Sciences (Biophysics), Moscow State University named MV Lomonosov, Moscow
1982 Associate Professor, Department of Biochemistry , Ogarev Mordovia State University , Saransk
1990 Doctor of Biological Sciences (Biophysics) , Moscow State University named MV Lomonosov, Moscow
1992 Professor of Biophysics speciality , Ogarev Mordovia State University , Saransk
1998 Honored Scientist of the Republic of Mordovia
2005 Honored Scientist of Russia .
2007 Honoured Scientist of the Russian Academy of Natural Sciences

Membership in professional societies:
Since 2003, Headed The Regional Mordovia Office of Russian Biotechnology Society, a member of the Presidium of the Russian State Training and Methodological Association of biological education, a member of EBTNA Executive Committee.

EBTNA Representative in Scotland

Nikolai Zhelev

Professor Nikolai Zhelev is an expert in Medical Biotechnology with extensive experience both in academia and the biopharmaceutical industry. He is an honorary Professor in eight universities in the UK, China, Bulgaria and Russia. Professor Zhelev has published three books, five book chapters and more than 100 research papers and patents in the field of DNA damage response, cell cycle regulation and drug discovery and development in oncology and cardiology. He is working with biopharmaceutical and biotech companies on the development of new drugs against cancer and cardiac hypertrophy. Professor Zhelev and been President of the International BioDiscovery Federation, Managing Editor of BioDiscovery – the first open access international scientific journal in the field of Life Sciences and Medicine in Scotland and a member of the editorial boards of fourteen international journals.

EBTNA Representative in Serbia

Viktor Nedovic

Dr. Viktor Nedovic is full professor at Deptartment of Food Technology and Biochemistry, Faculty of Agriculture, University of Belgrade, Republic of Serbia.

His research areas belong to biotechnology, food technology, and biochemical engineering. As author and co-author he has published over 400 articles, out of which more than 80 papers published in SCI journals and 30 as book chapters. In addition, he has edited four books for the renowned scientific publishers (Kluwer and Springer). His articles have been cited more than 1700 times, his h-index is 23 (Google Scholar). He has been coordinating or participating in more than 50 reserach and networking projects, out of which 30 are international ones, including four FP7, two FP6, five EUREKA projects, four COST actions, etc. He has visited and established cooperation with a dozen of universities and institutes all over the world.

Prof. Viktor Nedovic is founder and president of the Serbian Association of Food Technologists (SAFT) and coordinator of Serbian National Technology Platform “Food for Life”. In 2015 he become an associate member of the Academy of Engineering Sciences of Serbia (AESS). Besides it, he is a member of numerous national and international professional and scientific organizations, like: International Society of Food Engineering, ISFE; European Federation of Food Science and Technology, EFFoST (in the period 2007-2011 and again from 2013 he has been the EFFoST Executive Committee member); European Hygienic Engineering & Design Group (General Secretary of Regional Section Serbia), EHEDG; European Academy of Food Engineering (EAFE). Since 2015 he is a member of International Advisory Board of Latvia University of Agriculture.

He has been a member of scientific boards of more then 40 international food and biotechnology congresses. He is organizer of national competition of the best PhD thesis in the field of food engineering and food technology and the member of the international evaluation committee at the European competition, and also initiator and organizer of national student’s competition in the creation of eco-innovative food products, EcoTrophelia Serbia, under the umbrella of EcoTrophelia Europe, where he serves as member of the international jury.

He is also coordinator of Priority Area 7 (PA7) of the EU Strategy for the Danube Region (EUSDR), Knowledge Society, that is related to research, higher education and ICT. 

EBTNA Representative in Siberia

Alla B Salmina

Professor

Krasnoyarsk State Medical University
Russia

Biography

Alla B. Salmina (nee – Alla B. Egorova), M.D., Ph.D., Dr. Med. Sci., female, researcher in the area of Biochemistry, Pathophysiology, Neurochemistry, Molecular and Translational Medicine, graduated from the Krasnoyarsk State Medical University in 1992. Visiting Researcher at the Dept. Of Biophysical Genetics, Kanazawa University Graduate School of Medicine (Japan, 1993-1994, 1997-1998), and at the Dept. Of Biology, Biochemistry and Genetics, Torino University School of Medicine (Italy, 2000-2001).  Professor & Head of the Dept. Of Biochemistry, Medical, Pharmaceutical and Toxicological Chemistry, Head of the Research Institute of Molecular Medicine and Pathobiochemistry, and Vice-Rector on Innovative Development and International Affairs, Krasnoyarsk State Medical University named after Professor V.F.Voino-Yasenetsky (Russia) (since 2002). Author of more than 130 papers published in Russian and international peer-reviewed journals. Recipient of the Gold Medal for Young Scientists given by the Russian Academy of Sciences (1999), and the Young Scientist Award of the Government of Russian Federation for Achievements in Science and Technology (2011)

Research Interest

Biochemistry, Neurochemistry & Cell Biology, Integrative Neuroscience, Biophysics, Optical Biopsy, Programmed cell death, mitochondrial dysfunction, Signal transduction, regulation of steroidogenesis in reproductive system and brain, Molecular mechanisms of endothelial dysfunction, Molecular & Translational Medicine

EBTNA Representative in Slovakia

Prof Juraj Krajcovic

Dr. Juraj Krajcovic is currently Professor of Molecular Biology at the Department of Biology, Faculty of Natural Sciences University of SS Cyril & Methodius in Trnava, Slovakia. Till January 2017 his scientific and pedagogical career was primarily connected with the Faculty of Natural Sciences, Comenius University in Bratislava, Slovakia. Here he graduated in Biology in 1978, obtained his PhD in 1987 and was teaching different subjects in this area to undergraduate and postgraduate students. Within years 1997-2011 he was a director of the Institute of Cell Biology and Biotechnology there. His favorite research object/model organism is the flagellate Euglena gracilis especially its plastids. Current Research Interests: Molecular cell biology; gene structure and expression; protein import into organelles, primarily chloroplasts; molecular diagnostics; molecular evolution, DNA identification of microorganisms, plastids as drug targets; the origin and evolution of the cell; extremophiles, algae as photobioreactors. Teaching activities: General biology, Molecular cell biology, Genetics, Evolutionary biology; Selected chapters in microbiology and biotechnology. 
E-mail:  juraj.krajcovic@ucm.sk; juraj.krajcovic55@gmail.com

EBTNA Representative in Slovenia

Polona Znidaršic Plazl

Prof. Dr. Polona Znidaršic Plazl is employed at the Faculty of Chemistry and Chemical Technology of University of Ljubljana as a professor of biotechnology. She graduated in Chemical Engineering, obtained her Master degree in Biochemistry and her PhD at University of Ljubljana in 2000. Among research activities performed at several academic and industrial institutions in USA and EU, she spent half a year at Oregon State University as a Fulbright scholar in 2014/15. Her recent major research interests are biotransformations, the application of microreactor technology in biotechnology and microbial production of enzymes. She was Principal Investigator of 2 EU FP7 projects in the field of microbioreactor development. Among others, she is a Co-chair of the series of International Conferences on Implementation of Microreactor Technology in Biotechnology (IMTB) and a member of the Scientific Committee of the European Session on Applied Biocatalysis (ESAB) of the European Federation of Biotechnology (EFB).

EBTNA Representative in Spain

Prof Oscar Vicente

Oscar Vicente graduated in Biochemistry in 1976 and obtained his PhD in Sciences in 1983 in Madrid (Spain). After a three-year postdoctoral period at the Friedrich-Miescher Institut in Basel (Switzerland), Oscar Vicente moved in 1988 to the Institute of Microbiology and Genetics, University of Vienna (Austria), where he established and led a research group working on different aspects of plant reproductive biology and its biotechnological applications, and on the molecular characterization of pollen allergens and plant MAP kinases. As Assistant Professor from 1991 to 1996, he was responsible for several courses of Experimental Genetics taught at the Faculty of Sciences. Oscar Vicente returned to Spain in 1996 to join the faculty of the Polytechnic University of Valencia, where he is currently a Professor of Biochemistry and Molecular Biology at the Department of Biotechnology, teaching different subjects in this area to students of Biotechnology and Biomedical Engineering. His research interest focuses on studying plant responses to abiotic stress and stress tolerance mechanisms in the context of climate change. Oscar Vicente has published over 170 ISI-indexed scientific papers, most in the category of Plant Science. He is Vice-president and coordinator for Spain of the European Biotechnology Thematic Network Association (EBTNA) and is included in the ‘Top-100’ Spanish scientists in Plant Science and Agronomy (Research.com). In 2017, he was awarded the degree of Doctor Honoris Causa by the University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca (Romania).

EBTNA Representative in Turkey

Prof Munis Dündar, Coordinator

He was born May 2, 1961. He took undergraduate degree at Erciyes University, Faculty of Medicine in 1985. He made Ph.D. on Medical Genetics at Duncan Guthrie Institute of Medical Genetics, University of Glasgow/Scotland in 1994 and got Professor Title in 2003. He is founder and head of Medical Genetics Department at Erciyes University and he has been currently carrying out various administrative tasks since 1996.

He took part as Project Coordinator and Assistant Investigator in many research projects and many prepared articles out of them have been publishing in international journals since 1995. He is a lecturer at European University Consortium, Job Creation Oriented Biotechnology for first level degree and master program students, since 2006. He was president of the Turkish Medical Genetic Society between 2008-2010 and he is of EPMA in Turkey and EBTNA President (European Biotechnology Thematic Network Association).

Red Biotechnology Board (Health Medical Diagnostics)

Blue Biotechnology Board (AquacultureCoastal and Marine Biotech)

Yellow Biotechnology Board (Food Biotechnology Nutrition Science)

Green Biotechnology Board (Agricultural Environmental Biotechnology Biofuels Biofertilizers Bioremediation & Geomicrobiology)

Brown Biotechnology Board (Arid Zone and Desert Biotechnology)

White Biotechnology Board (Gene-based Bioindustries)

Dark Biotechnology Board (Bioterrorism Biowarfare Biocrimes Antcrop warfare)

Members
Aygül Ekici
Ahu Altınkut Uncuoglu
Munis Dündar
Feride Şahin
Hilal Akalın
Hande Yapışlar
Haydar Bağış
Hilal Özdağ
İlhan Demirhan
Muge Sirvani
Nazife Tascioglu
Nurdan Tozun
Selma Ozturk
Sevnur Mandaci
Ahmet Okay Caglayan
Seher Polat
Tijen Ogras
Tayfun Ozcelik
Turgay Tekinay
Ugur Ozbek
Yagut Akbarova
Oguzhan Bahadır

EBTNA Representative in UK

Prof Iza Radecka, Coordinator

Iza has an MSc in Biological Sciences from the University of Silesia, Poland completed in 1990. Within biosciences her research first focused on anatomy and histology (interactions between heavy metals and enzymatic activity in brain tissue). In 1991 she took a position as a junior research worker in the Institute of Polymer Chemistry at the Polish Academy of Sciences in Zabrze, Silesia, with a special interest in the biodegradability of different synthetic polymer blends. After one year there she decided to take a PhD researcher/lecturer post at the University of Silesia, Katowice, Poland with a special interest in microbial biotechnology concerning the production of biodegradable polymers by bacteria under different environmental conditions. She completed her PhD in the Department of Biochemistry, University of Silesia, Katowice, Poland. After that in 2000, she joined the School of Applied Sciences at the University of Wolverhampton, United Kingdom. Since then, her research is focused on the cost-effective synthesis of new biomaterials using bacterial biopolymers, produced from bacteria using eco-sustainable feedstock and their chemical derivatization which can transform the crude polymer into a range of highly valuable products. Her research also focuses on the application of biomaterials for drug delivery systems and the use of antimicrobial agents in wound dressing

She has published numerous research papers (80+) in highly ranked scientific journals, authored several chapters in biotechnological books. Iza has co-edited two books, and she has more than 90 conference proceedings. Iza has an active research group and has supervised successfully to completion above 60+ postgraduate students to date. Her h-index is 28, and her work has been cited more than 3000 times.

Iza has also given a broad number of invited lectures at international conferences. She has coordinated and participated to funded research projects at the EU as well as national level around biopolymers, nanoparticles and bioactive cements. Iza teaches on a wide variety of microbiology and biotechnology courses, both undergraduate and postgraduate level where she puts her knowledge and experience to good effect. Iza is also a Fellow of the Royal Society of Biology.

EBTNA Representative in Ukraine

Prof. Yaroslav Blume, Full Member of the Natl. Academy of Sciences of Ukraine (2006), Director of Inst. of Food Biotechnology and Genomics (from 2008), Head of Department of Genomics and Molecular Biotechnology. M.S. (Biochemistry) from Kyiv State University (1978), Ph.D. (1982), Dr. Sci. (Dr. Hab.) (1988), Prof. (2006). His scientific career started in Kyiv Univ., continuing in Natl. Acad. of Sci. of Ukraine, long time in Inst. of Cell Biology and Genetic Engineering (1989-2008). He was a visiting scientist at Univ. of Freiburg (1997), Canadian Food Inspection Agency, Ottawa (1998), John Innes Center, Norwich (1998-2003), Antwerpen Univ. (2005-2006), invited professor at Schiller Univ., Jena (2001).

Research activity of Ya. Blume is aimed at cell biology, genomics and biotechnology of plant cytoskeleton and cell signalling as well as a development of new tools for molecular biotechnology, creation of plants with novel traits, especially for biofuel production. In the field of cell biology he is focused on cellular and molecular signalling mechanisms underlying the influence of (a)biotic  factors on plant cells and investigation of the role of cytoskeletal structures in these processes. He analyzes the role and the place of cytoskeleton (microtubules and microfilaments) in the response of plant cell to ultraviolet (UV-B) irradiation, cold, high temperatures, heavy metals, herbicides with antimitotic activity as well as in the autophagy mechanisms. Such posttranslational modifications of plant α- and/or β-tubulin as phosphorylation, polyglutamylation, acetylation and tyrosine nitration were identified.

During last decade new tools of structural bioinformatics have been intensively developed by Ya. Blume and introduced for the identification of key cytoskeletal proteins involved in plant cell cycle regulation; 3D-modelling and the functional study of of cytoskeleton-related proteins; creation of the databases and the search of low-molecular weight compounds with high affinity to targeted cytoskeletal proteins, plant and bacterial FtsZ-proteins, protein kinases and phosphatases; the molecular design of biologically active compounds and their high throughput screening in silico. Original structural biological approaches for 3D-modelling of plant tubulin and other cytoskeletal proteins have been developed.

Important part of his efforts is concentrated on such plant molecular genetics, genomics and molecular biotechnological investigations as the development of the molecular markers for genes related to specific agronomic traits, including QTL-loci; the development and implementation of the molecular genetic approaches for identification of wheat and barley resistant genes to different pathogens (leaf, yellow and stem rust resistance genes, namely); the screening of the existing wheat and barley collections for presence resistance genes to these deseases; the study of the genetic diversity of wild relatives of cultivated cereals (e.g., Aegilops sp.) as a potential source of useful genes.

Ya. Blume conducting out the projects directed on the improvement of the efficiency of Agrobacteruim-mediated and biolistic plant transformation and development of new methods for the gene transfer using nanoparticles, carbon nanotubes and other nanopolymers. Respective transformation techniques for transgenic plant production with the desired traits such as herbicides or insect pest resistance have been developed (barley, finger millet, sugar beet, potato, flax, tobacco, false flax and soybean). The sequential study of the mutations of cytoskeletal proteins in the formation of plant resistance to herbicides with antimitotic activity allowed him to obtain mutant plants, isolate altered tubulin genes responsible for herbicide resistance and, finally, to obtain plants resistant to these chemicals. New safe and environmentally friendly marker system for the selection of the transformed plant lines based on mutant tubulin gene was developed. Transgenic plants were used as “green factories” for the production of such pharmacalogically valuable product as lactoferrin.

Under his supervision new methods of nanobiotechnology have been developed recently, namely the production (“green synthesis”) of nanoparticles and quantum dots by biological systems.

With his participation new varieties of finger millet, sweet sorghum, false flax and miscanthus for biofuel production were obtained employing molecular breeding approaches. Original technologies for bioethanol production from sweet sorghum and finger millet were developed as well as the technology of biodiesel production based from bioethanol and false flax (camelina) oils for engines has been developed and the pilot equipment has been constructed.

Ya.B. Blume is Editor-in-chief of “Cytology and Genetics” (from 2006) and “The Open Agriculture Journal” (from 2017). Author and co-author more than 280 research publications, 11 patent inventions and 9 plant varieties.

The State Prize of Ukraine (2011), Certificate of Achievements from the Parliament of Ukraine (2011),

the Prize of Natl. Academy of Sci. in Genetics (2002). Honorary State Title "Distinguished Person in Science and Techniques in Ukraine" (2016), Honours from Natl. Academy of Sci. of Ukraine “For Training Academic  Changing” (2017) and “For Scientific Achievements” (2016).

EBTNA Representative in United States of America

Prof. Lal Ratnesh

Prof. Lal received his MS/M Phil in Physics/Biophysics from JNU, India, Ph.D. in Neurobiology from UAB, and postdoctoral training at Caltech. He held faculty positions at the University of Chicago and UCSB and then the Director of the Center of Nanomedicine and professorships in Medicine, Biophysical Sciences and Cell Physiology at the University of Chicago. Currently, he holds joint professorships in Bioengineering, Mechanical Engineering, and Materials Science, and is the co-Director for the Center for Excellence in Nanomedicine and Engineering at UCSD. He is a Fellow of AAAS (the American Association for Advancement of Science) and a Fellow of the American Institute of Medical and Biological Engineering (AIMBE). He was the UTS Invited Professor in Sydney for their Bionanotechnology initiative and a New Zealand Government International Science Scholar. He is a Visiting Professor at the Chinese Academy of Sciences, Institute for Applied Physics, Shanghai. He is an Associate Editor of the Journal Nanomedicine: Nanotechnology, Biology, Medicine. He is the Chairman of American Nanoslutions, LLC, Vessel ANI corp and is on advisory board of RC Nano LLC and Be Green Packaging LLC. He has presented many international keynote lectures and is featured in many popular magazines and news media, including Time and Smithsonian. He holds several patents based upon AFM cantilever arrays, microfluidics, optoelectronics and nanotubes for medical diagnostics, Nano biosensors and in-vivo medical Nano devices, nanoscale fluid behavior and new TIRF, FRET and related optical microscopy